An 11-year-old girl in Cambodia has lost her life to&nbsp;bird flu, also known as avian influenza, Associated Press reported quoting health officials.&nbsp;This is the first known human H5N1 infection in Cambodia since 2014.

In 2014, new human cases of avian influenza were confirmed for the H5N1 virus in the country. As per World Health Organization, H5N1 avian influenza viruses circulate in poultry and pose&nbsp;a risk for sporadic infection due to exposure to infected poultry.&nbsp;

Also Read | <a href="https://www.wionews.com/world/european-commission-bans-staff-from-using-tiktok-on-work-devices-amid-security-concerns-565148">European Commission bans staff from using TikTok on work devices amid security concerns</a>

The first outbreak of avian influenza A (H5N1) virus in humans occurred in Hong Kong in 1997. Till that year, the cases of bird flu were not taken to be posing a major threat. The 1997 outbreak was put to an end by a carrying out a massive culling of over 1.5 million chickens.&nbsp;

Even though many of these cases are a result of direct touch with infected poultry, it must be noted that the nature of influenza viruses are constantly evolving. With this, there are concerns if the virus could evolve to spread more easily between people.

The newly reported case is from the rural southeastern province of Prey Veng. The girl fell sick on February 16 and was taken to a Phnom Penh hospital.&nbsp;Later on Wednesday, she was diagnosed with a fever of up to 39 Celsius (102 Fahrenheit) along with other symptoms including coughing and throat pain. Soon, she was declared dead, the news agency said quoting country's health ministry.&nbsp;

Also Read | <a href="https://www.wionews.com/world/one-year-of-war-against-ukraine-acting-together-to-ensure-international-law-will-prevail-565158">One year of war against Ukraine: Acting together to ensure international law will prevail</a>

Medical officials took samples from a dead wild bird at a conservation area near the girl's home to understand the virus better. The ministry said teams in the area would be cautioning residents about touching dead and sick birds. As per WHO, Cambodia had 56 human cases of H5N1 from 2003 through 2014 and 37 of them were fatal.&nbsp;

Watch | <a href="https://www.wionews.com/videos/russia-ukraine-war-vladimir-putin-talks-of-boosting-nuclear-forces-565118">Russia Ukraine War: Vladimir Putin talks of boosting nuclear forces</a>

Earlier this month,&nbsp;WHO Director-General Tedros Adhanom Ghebreyesus flagged concern about avian influenza infections in mammals.&nbsp;"H5N1 has spread widely in wild birds and poultry for 25 years, but the recent spillover to mammals needs to be monitored closely," he had said.

WATCH WION LIVE HERE

<iframe allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen="" frameborder="0" height="350" loading="”lazy”" src="https://www.wionews.com/live-tv/embed?autoplay=1&amp;mute=1  width=&quot;100%&quot;"></iframe>

You can now write for wionews.com and be a part of the community. Share your stories and opinions with us <a href="https://www.wionews.com/content-contribution-registration-form">here</a>.

An 11-year-old girl in Cambodia has lost her life to bird flu, also known as avian influenza, Associated Press reported quoting health officials. This is the first known human H5N1 infection in Cambodia since 2014.

An 11-year-old girl in Cambodia has lost her life to bird flu, also known as avian influenza, Associated Press reported quoting health officials. This is the first known human H5N1 infection in Cambodia since 2014. In 2014, new human cases of avian influenza were confirmed for the H5N1 virus in the country. As per World Health Organization, H5N1 avian influenza viruses circulate in poultry and pose a risk for sporadic infection due to exposure to infected poultry. Also Read | European Commission bans staff from using TikTok on work devices amid security concerns The first outbreak of avian influenza A (H5N1) virus in humans occurred in Hong Kong in 1997. Till that year, the cases of bird flu were not taken to be posing a major threat. The 1997 outbreak was put to an end by a carrying out a massive culling of over 1.5 million chickens. Even though many of these cases are a result of direct touch with infected poultry, it must be noted that the nature of influenza viruses are constantly evolving. With this, there are concerns if the virus could evolve to spread more easily between people. The newly reported case is from the rural southeastern province of Prey Veng. The girl fell sick on February 16 and was taken to a Phnom Penh hospital. Later on Wednesday, she was diagnosed with a fever of up to 39 Celsius (102 Fahrenheit) along with other symptoms including coughing and throat pain. Soon, she was declared dead, the news agency said quoting country's health ministry. Also Read | One year of war against Ukraine: Acting together to ensure international law will prevail Medical officials took samples from a dead wild bird at a conservation area near the girl's home to understand the virus better. The ministry said teams in the area would be cautioning residents about touching dead and sick birds. As per WHO, Cambodia had 56 human cases of H5N1 from 2003 through 2014 and 37 of them were fatal. Watch | Russia Ukraine War: Vladimir Putin talks of boosting nuclear forces Earlier this month, WHO Director-General Tedros Adhanom Ghebreyesus flagged concern about avian influenza infections in mammals. "H5N1 has spread widely in wild birds and poultry for 25 years, but the recent spillover to mammals needs to be monitored closely," he had said. WATCH WION LIVE HERE You can now write for wionews.com and be a part of the community. Share your stories and opinions with us here.

11-year old girl dies in Cambodia’s first bird flu case since 2014

Citizens living in India’s financial capital city Mumbai are neither fit nor healthy, reveals civic body BMC's health department in a STEPS (STEP-wise approach to Surveillance) survey devised by World Health Organisation (WHO). Total 5,199 citizens were surveyed from August to December 2021.

The survey found every third of Mumbaikar has hypertension, while every fifth has diabetes and another 15 per cent are pre-diabetic. Approximately, 8% of the surveyed population have both diabetes and hypertension.

Mumbaikars consume almost double the daily recommended amount of salt. While WHO recommends only 5g salt to be consumed, respondents consume 8.6g of salt.

STEPS survey also showed that one in five respondents has raised levels of cholesterol — a marker of heart disease. Almost 37 per cent in the 18-69 age group have three out of six factors of heart disease.

To remain fit and healthy, doctors advise to do basic exercise and eat healthy like fruits, vegetables etc., but the survey found that 74 per cent of respondents reported no fitness related physical activity in their daily routine.

“We now have a proper health chart of people living in Mumbai. To control hypertension and diabetes, we have started screening people and putting them on treatment. Overweight and obesity are also other common issues that citizens are facing. Our survey found almost 12 per cent of respondents are obese. More women than men are obese in the city,” said Dr Daksha Shah, BMC's joint executive health officer.

Other survey highlights

- 12% consume tobacco daily

- Nine out of 10 Mumbaikars don' eat fruits or vegetables

- 15% surveyed population is pre-diabetic

&nbsp;

WATCH WION LIVE HERE

<iframe allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen="" frameborder="0" height="350" loading="”lazy”" src="https://www.wionews.com/live-tv/embed?autoplay=1&amp;mute=1" width="100%"></iframe>

Citizens living in India’s financial capital city Mumbai are neither fit nor healthy, reveals civic body BMC's health department in a STEPS (STEP-wise approach to Surveillance) survey devised by World Health Organisation (WHO).

Citizens living in India’s financial capital city Mumbai are neither fit nor healthy, reveals civic body BMC's health department in a STEPS (STEP-wise approach to Surveillance) survey devised by World Health Organisation (WHO). Total 5,199 citizens were surveyed from August to December 2021. The survey found every third of Mumbaikar has hypertension, while every fifth has diabetes and another 15 per cent are pre-diabetic. Approximately, 8% of the surveyed population have both diabetes and hypertension. Mumbaikars consume almost double the daily recommended amount of salt. While WHO recommends only 5g salt to be consumed, respondents consume 8.6g of salt. STEPS survey also showed that one in five respondents has raised levels of cholesterol — a marker of heart disease. Almost 37 per cent in the 18-69 age group have three out of six factors of heart disease. To remain fit and healthy, doctors advise to do basic exercise and eat healthy like fruits, vegetables etc., but the survey found that 74 per cent of respondents reported no fitness related physical activity in their daily routine. “We now have a proper health chart of people living in Mumbai. To control hypertension and diabetes, we have started screening people and putting them on treatment. Overweight and obesity are also other common issues that citizens are facing. Our survey found almost 12 per cent of respondents are obese. More women than men are obese in the city,” said Dr Daksha Shah, BMC's joint executive health officer. Other survey highlights - 12% consume tobacco daily - Nine out of 10 Mumbaikars don' eat fruits or vegetables - 15% surveyed population is pre-diabetic WATCH WION LIVE HERE

India: Mumbai people neither fit nor healthy, reveals new govt survey

A woman dies during pregnancy or childbirth every two minutes, a new report by United Nations agencies released on Thursday (February 23) revealed. Lives of over one million more women may be at risk by 2030, "Trends in maternal mortality", the report, further underlines unless significant progress is made worldwide to meet global targets for reducing maternal deaths. Maternal deaths - nationally, regionally and globally from 2000 to 2020 - have been tracked as a part of the report. About 287,000 maternal deaths were recorded globally in 2020. A majority of these deaths have been recorded from the poorest of poor regions and conflict zones.

&nbsp;

<h2>WHO chief, others on maternal death alarming figures</h2>

 
“While pregnancy should be a time of immense hope and a positive experience for all women, it is tragically still a shockingly dangerous experience for millions around the world who lack access to high quality, respectful health care,” Dr Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization (WHO), was quoted as saying in an official release. In her response, UNFPA Executive Director Dr. Natalia Kanem stressed upon the need for political will to face the challenge. "It is unacceptable that so many women continue to die needlessly in pregnancy and childbirth. Over 280,000 fatalities in a single year is unconscionable. We can and must do better by urgently investing in family planning and filling the global shortage of 900,000 midwives so that every woman can get the lifesaving care she needs," she said.

Watch: Gravitas Plus: The world's fertility rate is falling. Here's why

<div class="ui-state-default" contenteditable="false">
<div class="twitter-block" draggable="false">
<div class="videoWrapper trancodeVideo"><iframe allowfullscreen="" autoplay="1" class="includeVideo" frameborder="0" height="350" src="https://www.wionews.com/videos/gravitas-plus-the-worlds-fertility-rate-is-falling-heres-why-432417/embed" style="width:100%;max-width:560px;" width="560"></iframe></div>
</div>
<a class="close-mark close-div" href="#" id="jqclosemark">×</a></div>

&nbsp;

&nbsp;

<h2>Maternal deaths: Worst-affected parts</h2>

<h2>&nbsp;</h2>

About 70 per cent of all maternal deaths in 2020 were registered in sub-Saharan Africa. Nine countries in the grips of severe humanitarian crises recorded maternal mortality rates more than double the world average as 551 maternal deaths were registered per 100,000 live births, compared to 223 globally.&nbsp; Among the leading causes of the deaths are severe bleeding, high blood pressure, pregnancy-related infections, and complications from unsafe abortion. About 270 million women lack access to modern family planning methods.

Also read: <a href="https://www.wionews.com/world/this-country-has-the-worlds-lowest-fertility-rate-breaks-its-own-record-564845">This country has the world's lowest fertility rate, breaks its own record</a>

However, several nations have been registering an improvement in the situation as far as these figures are concerned. Australia and New Zealand, and Central and South Asia experienced significant declines by 35 per cent and 16 per cent respectively in their maternal mortality rates during the same period, as did 31 countries across the world.

WATCH WION LIVE HERE

<iframe allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen="" frameborder="0" height="350" loading="”lazy”" src="https://www.wionews.com/live-tv/embed?autoplay=1&amp;mute=1  width=&quot;100%&quot;"></iframe>

You can now write for wionews.com and be a part of the community. Share your stories and opinions with us <a href="https://www.wionews.com/content-contribution-registration-form">here</a>.

A woman dies during pregnancy or childbirth every two minutes, a new report by United Nations agencies released on Thursday (February 23) revealed. Lives of over one million more women may be at risk by 2030, "Trends in maternal mortality", the report, further underlines unless significant progress is made worldwide to meet global targets for reducing maternal deaths.

A woman dies during pregnancy or childbirth every two minutes, a new report by United Nations agencies released on Thursday (February 23) revealed. Lives of over one million more women may be at risk by 2030, "Trends in maternal mortality", the report, further underlines unless significant progress is made worldwide to meet global targets for reducing maternal deaths. Maternal deaths - nationally, regionally and globally from 2000 to 2020 - have been tracked as a part of the report. About 287,000 maternal deaths were recorded globally in 2020. A majority of these deaths have been recorded from the poorest of poor regions and conflict zones. WHO chief, others on maternal death alarming figures “While pregnancy should be a time of immense hope and a positive experience for all women, it is tragically still a shockingly dangerous experience for millions around the world who lack access to high quality, respectful health care,” Dr Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization (WHO), was quoted as saying in an official release. In her response, UNFPA Executive Director Dr. Natalia Kanem stressed upon the need for political will to face the challenge. "It is unacceptable that so many women continue to die needlessly in pregnancy and childbirth. Over 280,000 fatalities in a single year is unconscionable. We can and must do better by urgently investing in family planning and filling the global shortage of 900,000 midwives so that every woman can get the lifesaving care she needs," she said. Watch: Gravitas Plus: The world's fertility rate is falling. Here's why × Maternal deaths: Worst-affected parts About 70 per cent of all maternal deaths in 2020 were registered in sub-Saharan Africa. Nine countries in the grips of severe humanitarian crises recorded maternal mortality rates more than double the world average as 551 maternal deaths were registered per 100,000 live births, compared to 223 globally. Among the leading causes of the deaths are severe bleeding, high blood pressure, pregnancy-related infections, and complications from unsafe abortion. About 270 million women lack access to modern family planning methods. Also read: This country has the world's lowest fertility rate, breaks its own record However, several nations have been registering an improvement in the situation as far as these figures are concerned. Australia and New Zealand, and Central and South Asia experienced significant declines by 35 per cent and 16 per cent respectively in their maternal mortality rates during the same period, as did 31 countries across the world. WATCH WION LIVE HERE You can now write for wionews.com and be a part of the community. Share your stories and opinions with us here.

UN report's staggering revelation on maternal deaths: 1 death every 2 minutes

A severe form of mpox virus - formerly known as monkeypox - has been found in immunosuppressed people living with HIV in advanced stage, a new study has underlined. The study - published in The Lancet journal - underlined that the virus was fatal in 15 per cent of those who were affected. "Emerging data suggest worse clinical outcomes and higher mortality in people with more advanced HIV," the report underlines. Professor Chloe Orkin, at Queen Mary University of London and Barts Health NHS trust, and colleagues carried out the study following reports of particularly severe mpox infections. A total of 382 cases were examined as a part of the study.

<h2>Defining symptoms of severe mpox</h2>

On Twitter, the scientist explained defining symptoms. "Skin rash was prolonged. The hallmark feature of this severe disseminated form of MPOX was large coalescing and necrotising lesions which occurred in 93 per cent of those who died. Sepsis occurred in 89 per cent of those who died and respiratory symptoms in 85 per cent," Orkin tweeted.

An immune reconstitution inflammatory syndrome to mpox, researchers pointed out, was suspected in 21 (25 per cent) of 85 people initiated, of whom 12 (57 per cent) of 21 died.&nbsp; Of the total 382 cases, 367 were men.

Also Watch| WION Fineprint: Monkeypox gets new name Mpox

<div class="ui-state-default" contenteditable="false">
<div class="twitter-block" draggable="false">
<div class="videoWrapper trancodeVideo"><iframe allowfullscreen="" autoplay="1" class="includeVideo" frameborder="0" height="350" src="https://www.wionews.com/videos/wion-fineprint-monkeypox-gets-new-name-mpox-538622/embed" style="width:100%;max-width:560px;" width="560"></iframe></div>
</div>
<a class="close-mark close-div" href="#" id="jqclosemark">×</a></div>

<h2>The multicountry mpox outbreak</h2>

The multicountry mpox outbreak triggered massive concerns last year as experts feared another pandemic. More than 85,000 cases have been so far reported, as of February 15, linked to the virus which was at one time largely confined to Africa, according to the Centers for Disease Control and Prevention. Of the total cases, 84,590 patients were registered in locations that have not historically reported mpox.

Also read: <a href="https://www.wionews.com/world/who-maintains-its-stance-public-health-emergency-alert-for-mpox-562453">WHO maintains its stance; public health emergency alert for mpox to continue</a>

In November, the World Health Organization (WHO) changed the name of the virus from monkeypox to mpox over concerns of stigma associated with the name. "When the outbreak of monkeypox expanded earlier this year, racist and stigmatising language online, in other settings and in some communities was observed and reported to WHO. In several meetings, public and private, a number of individuals and countries raised concerns and asked WHO to propose a way forward to change the name," the global health body noted.

&nbsp;

WATCH WION LIVE HERE

<iframe allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen="" frameborder="0" height="350" loading="”lazy”" src="https://www.wionews.com/live-tv/embed?autoplay=1&amp;mute=1  width=&quot;100%&quot;"></iframe>

You can now write for wionews.com and be a part of the community. Share your stories and opinions with us <a href="https://www.wionews.com/content-contribution-registration-form">here</a>.

A severe form of mpox virus - formerly known as monkeypox - has been found in immunosuppressed people living with HIV in advanced stage, a new study has underlined.

A severe form of mpox virus - formerly known as monkeypox - has been found in immunosuppressed people living with HIV in advanced stage, a new study has underlined. The study - published in The Lancet journal - underlined that the virus was fatal in 15 per cent of those who were affected. "Emerging data suggest worse clinical outcomes and higher mortality in people with more advanced HIV," the report underlines. Professor Chloe Orkin, at Queen Mary University of London and Barts Health NHS trust, and colleagues carried out the study following reports of particularly severe mpox infections. A total of 382 cases were examined as a part of the study. Defining symptoms of severe mpox On Twitter, the scientist explained defining symptoms. "Skin rash was prolonged. The hallmark feature of this severe disseminated form of MPOX was large coalescing and necrotising lesions which occurred in 93 per cent of those who died. Sepsis occurred in 89 per cent of those who died and respiratory symptoms in 85 per cent," Orkin tweeted. An immune reconstitution inflammatory syndrome to mpox, researchers pointed out, was suspected in 21 (25 per cent) of 85 people initiated, of whom 12 (57 per cent) of 21 died. Of the total 382 cases, 367 were men. Also Watch| WION Fineprint: Monkeypox gets new name Mpox × The multicountry mpox outbreak The multicountry mpox outbreak triggered massive concerns last year as experts feared another pandemic. More than 85,000 cases have been so far reported, as of February 15, linked to the virus which was at one time largely confined to Africa, according to the Centers for Disease Control and Prevention. Of the total cases, 84,590 patients were registered in locations that have not historically reported mpox. Also read: WHO maintains its stance; public health emergency alert for mpox to continue In November, the World Health Organization (WHO) changed the name of the virus from monkeypox to mpox over concerns of stigma associated with the name. "When the outbreak of monkeypox expanded earlier this year, racist and stigmatising language online, in other settings and in some communities was observed and reported to WHO. In several meetings, public and private, a number of individuals and countries raised concerns and asked WHO to propose a way forward to change the name," the global health body noted. WATCH WION LIVE HERE You can now write for wionews.com and be a part of the community. Share your stories and opinions with us here.

Deadlier mpox virus found in people with advanced HIV: Lancet Study

The World Health Organization on Wednesday said that despite a dip in the number of cases, it still considers mpox, previously known as monkeypox, an international health emergency.&nbsp; WHO director-general Tedros Adhanom Ghebreyesus, as per AFP, reached this&nbsp;conclusion following the recommendations of the UN health agency's emergency committee. The committee met last Friday.

Watch |&nbsp;WION Fineprint: Monkeypox gets new name Mpox

<div class="videoWrapper trancodeVideo"><iframe allowfullscreen="" autoplay="1" class="includeVideo" frameborder="0" height="350" src="https://www.wionews.com/videos/wion-fineprint-monkeypox-gets-new-name-mpox-538622/embed" style="width:100%;max-width:560px;" width="560"></iframe></div>

Speaking to the press, Tedros said, "The committee has advised me that in its view, mpox remains a global health emergency, and I have accepted that advice."&nbsp;

Officials noticed a surge in what was earlier known as monkeypox infections last May. The surge&nbsp;outside African countries where the infection has long been an endemic was noticed&nbsp;among men who have sex with men.&nbsp;To date, 85,860 cases have been reported from 110 countries.

Also read |&nbsp;<a href="https://www.wionews.com/world/who-to-rename-monkeypox-as-mpox-after-pressure-from-us-report-536629">WHO to rename monkeypox as ‘MPOX’ over stigma, pressure from US: Report</a>

The disease was first spotted in humans in 1970 in the Democratic Republic of the Congo region. Since then,&nbsp;the disease spread among humans but has, for the most part, been limited to certain West and Central African nations.

However, last May, cases of the disease began spreading rapidly around the world. Following the sudden influx of cases,&nbsp;the WHO on&nbsp;July 23, 2022, triggered a public health emergency of international concern (PHEIC).

Also read |&nbsp;<a data-ctorig="https://www.wionews.com/science/the-nitty-gritty-of-monkeypox-500608" data-cturl="https://www.google.com/url?client=internal-element-cse&amp;cx=006054055338965708568:09spwrlibei&amp;q=https://www.wionews.com/science/the-nitty-gritty-of-monkeypox-500608&amp;sa=U&amp;ved=2ahUKEwjpsvqlj5j9AhXVR2wGHaAGBccQFnoECAkQAg&amp;usg=AOvVaw0mZT85gPQorUgduTePQVHb" dir="ltr" href="https://www.wionews.com/science/the-nitty-gritty-of-monkeypox-500608" target="_blank">The nitty-gritty of&nbsp;Monkeypox&nbsp;</a>

Since then, the WHO's emergency committee on mpox meets every three months to determine the validity of the said&nbsp;label. As per Tedros, while the&nbsp;committee acknowledged the progress made in reducing transmission of the diseases, 30 nations are still reporting cases. He also pointed out that in some of the regions,&nbsp;not all cases might have been detected and reported. Due to this, he said all&nbsp;countries should remain vigilant.

(With inputs from agencies)

WATCH WION LIVE HERE

<iframe allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen="" frameborder="0" height="350" loading="”lazy”" src="https://www.wionews.com/live-tv/embed?autoplay=1&amp;mute=1" width="100%"></iframe>

You can now write for wionews.com and be a part of the community. Share your stories and opinions with us <a href="https://www.wionews.com/content-contribution-registration-form">here</a>.

The World Health Organization on Wednesday said that despite a dip in the number of cases, it still considers mpox, previously known as monkeypox, an international health emergency.

The World Health Organization on Wednesday said that despite a dip in the number of cases, it still considers mpox, previously known as monkeypox, an international health emergency. WHO director-general Tedros Adhanom Ghebreyesus, as per AFP, reached this conclusion following the recommendations of the UN health agency's emergency committee. The committee met last Friday. Watch | WION Fineprint: Monkeypox gets new name Mpox Speaking to the press, Tedros said, "The committee has advised me that in its view, mpox remains a global health emergency, and I have accepted that advice." Officials noticed a surge in what was earlier known as monkeypox infections last May. The surge outside African countries where the infection has long been an endemic was noticed among men who have sex with men. To date, 85,860 cases have been reported from 110 countries. Also read | WHO to rename monkeypox as ‘MPOX’ over stigma, pressure from US: Report The disease was first spotted in humans in 1970 in the Democratic Republic of the Congo region. Since then, the disease spread among humans but has, for the most part, been limited to certain West and Central African nations. However, last May, cases of the disease began spreading rapidly around the world. Following the sudden influx of cases, the WHO on July 23, 2022, triggered a public health emergency of international concern (PHEIC). Also read | The nitty-gritty of Monkeypox Since then, the WHO's emergency committee on mpox meets every three months to determine the validity of the said label. As per Tedros, while the committee acknowledged the progress made in reducing transmission of the diseases, 30 nations are still reporting cases. He also pointed out that in some of the regions, not all cases might have been detected and reported. Due to this, he said all countries should remain vigilant. (With inputs from agencies) WATCH WION LIVE HERE You can now write for wionews.com and be a part of the community. Share your stories and opinions with us here.

WHO maintains its stance; public health emergency alert for mpox to continue

The World Health Organization (WHO) declared on Tuesday that the monkeypox outbreak still qualifies as a global health emergency and should be treated as such.&nbsp;

As per Reuters, a "public health emergency of international concern (PHEIC)", is WHO's highest level of alert and is designed to trigger a coordinated international response and could unlock funding to collaborate on sharing vaccines and treatments.

Watch |&nbsp;'Do not touch foreigners to avoid monkeypox', Chinese doctor tells citizens

<div class="videoWrapper trancodeVideo"><iframe allowfullscreen="" autoplay="1" class="includeVideo" frameborder="0" height="350" src="https://www.wionews.com/videos/do-not-touch-foreigners-to-avoid-monkeypox-chinese-doctor-tells-citizens-517918/embed" style="width:100%;max-width:560px;" width="560"></iframe></div>

This was done following the third meeting of the International Health Regulations (IHR) Emergency Committee regarding the multi-country outbreak of monkeypox, held on October 22.

Since the last meeting, improvements have been made in the international response to the multi-nation monkeypox outbreak, including a new understanding of the efficacy of behavioural therapies and vaccines, said the WHO Emergency Committee.&nbsp;

Also read |&nbsp;<a href="https://www.wionews.com/world/new-zealand-reports-first-community-transmission-of-monkeypox-two-new-cases-522891">New Zealand reports first community transmission of monkeypox, two new cases</a>

However, the Committee voiced its belief that the situation still satisfies the IHR's requirements for a Public Health Emergency of International Concern (PHEIC).

As per the committee, a number of reasons are contributing to the ongoing concerns.

These include "ongoing transmission in some regions, continuing preparedness and response inequity within and between WHO Member States, an emerging potential for greater health impact in vulnerable populations, continuing risk of stigma and discrimination, weak health systems in some developing countries, leading to under-reporting, ongoing lack of equitable access to diagnostics, antiviral and vaccines, and research gaps" that need to be addressed.

Also read |&nbsp;<a href="https://www.wionews.com/world/us-early-data-shows-monkeypox-vaccine-to-be-highly-effective-520682">US: Early data shows monkeypox vaccine to be highly effective</a>

It further acknowledged that while cases are declining globally, the "picture is mixed".

The risk assessment conducted by the WHO Secretariat concluded that as of 18 October 2022, the public health risk remains moderate globally.

Regionally, the risk was rated as high for the WHO region of the Americas, moderate in the European region (where it went from high to moderate), and low in the Western Pacific region. It remains moderate in the WHO regions of Africa, the Eastern Mediterranean, and South-East Asia.

(With inputs from agencies)

WATCH WION LIVE HERE

<iframe allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen="" frameborder="0" height="350" loading="”lazy”" src="https://www.wionews.com/live-tv/embed?autoplay=1&amp;mute=1" width="100%"></iframe>

You can now write for wionews.com and be a part of the community. Share your stories and opinions with us <a href="https://www.wionews.com/content-contribution-registration-form">here</a>.

The World Health Organization (WHO) declared on Tuesday that the monkeypox outbreak still qualifies as a global health emergency and should be treated as such. As per Reuters, a "public health emergency of international concern (PHEIC)", is WHO's highest level of alert and is designed to trigger a coordinated international response and could unlock funding to collaborate on sharing vaccines and treatments.

The World Health Organization (WHO) declared on Tuesday that the monkeypox outbreak still qualifies as a global health emergency and should be treated as such. As per Reuters, a "public health emergency of international concern (PHEIC)", is WHO's highest level of alert and is designed to trigger a coordinated international response and could unlock funding to collaborate on sharing vaccines and treatments. Watch | 'Do not touch foreigners to avoid monkeypox', Chinese doctor tells citizens This was done following the third meeting of the International Health Regulations (IHR) Emergency Committee regarding the multi-country outbreak of monkeypox, held on October 22. Since the last meeting, improvements have been made in the international response to the multi-nation monkeypox outbreak, including a new understanding of the efficacy of behavioural therapies and vaccines, said the WHO Emergency Committee. Also read | New Zealand reports first community transmission of monkeypox, two new cases However, the Committee voiced its belief that the situation still satisfies the IHR's requirements for a Public Health Emergency of International Concern (PHEIC). As per the committee, a number of reasons are contributing to the ongoing concerns. These include "ongoing transmission in some regions, continuing preparedness and response inequity within and between WHO Member States, an emerging potential for greater health impact in vulnerable populations, continuing risk of stigma and discrimination, weak health systems in some developing countries, leading to under-reporting, ongoing lack of equitable access to diagnostics, antiviral and vaccines, and research gaps" that need to be addressed. Also read | US: Early data shows monkeypox vaccine to be highly effective It further acknowledged that while cases are declining globally, the "picture is mixed". The risk assessment conducted by the WHO Secretariat concluded that as of 18 October 2022, the public health risk remains moderate globally. Regionally, the risk was rated as high for the WHO region of the Americas, moderate in the European region (where it went from high to moderate), and low in the Western Pacific region. It remains moderate in the WHO regions of Africa, the Eastern Mediterranean, and South-East Asia. (With inputs from agencies) WATCH WION LIVE HERE You can now write for wionews.com and be a part of the community. Share your stories and opinions with us here.

Cases declining but monkeypox remains a 'global health emergency': WHO

Africa has reported a new virus outbreak. This virus is reportedly as deadly as Ebola. At least 9 people have already died. The WHO has called for an emergency meeting. Should you be worried?

Gravitas: Equatorial Guinea reports 9 Marburg deaths. WHO calls for an emergency meeting

On Sunday, World Health Organisation chief Tedros Adhanom Ghebreyesus said that Syrian President Bashar al-Assad is open for more border crossings so that aid can be reached to the quake victims in the rebel-held northwest Syria.

Ghebreyesus held talks with the Syrian president in Damascus as the two discussed the response to the Turkey-Syria earthquake.&nbsp;

"The compounding crises of conflict, Covid, cholera, economic decline and now the earthquake have taken an unbearable toll," said Tedros after he visited Aleppo and saw the devastation.&nbsp;

ALSO READ | <a href="https://www.wionews.com/world/un-acknowledges-relief-failure-in-syria-as-earthquake-toll-reaches-33000-561279">UN acknowledges relief failure in Syria as earthquake toll reaches 33,000</a>

He said he was "waiting to move across lines to the northwest, where we've been told the impact is even worse".

The situation has worsened in the rebel-held areas where aid convoys cannot reach the country's government-held without the authorisation of Damascus.

The single border crossing which was open for the transfer of aid was also disrupted by the earthquake.

"This afternoon I met with &nbsp;President Assad, who indicated he was open to considering additional cross-border access points for this emergency," said Tedros. during a virtual press conference from the Syrian capital.

Tedros appreciated the "recent blanket approval by the government of Syria for the UN for cross-line conveys" to transfer aid into the rebel-held areas.

However, he added that although cross-line aid convoys have been given the all-clear by Damascus to enter government-held areas, WHO is still waiting for the green light. "We're on standby," he said.&nbsp;

WATCH | Syria allows aid delivery to rebel-hit areas

<div class="videoWrapper trancodeVideo"><iframe allowfullscreen="" autoplay="1" class="includeVideo" frameborder="0" height="350" src="https://www.wionews.com/videos/syria-allows-aid-delivery-to-rebel-hit-areas-560955/embed" style="width:100%;max-width:560px;" width="560"></iframe></div>

WHO's director for the Eastern Mediterranean region Richard Brennan said that there had been "no cross-line deliveries since the earthquake struck".

"We did have one scheduled in the next couple of days. We are still negotiating for that to go ahead," he added.

(With inputs from agencies)

You can&nbsp;now write for wionews.com&nbsp;and be a part of the community. Share your stories and opinions with us&nbsp;<a href="https://www.wionews.com/content-contribution-registration-form">here</a>.

WATCH WION LIVE HERE

<iframe allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen="" frameborder="0" height="350" src="https://www.wionews.com/live-tv/embed?autoplay=1&amp;mute=1" width="100%"></iframe>

On Sunday, World Health Organisation chief Tedros Adhanom Ghebreyesus said that Syrian President Bashar al-Assad is open for more border crossings so that aid can be reached to the quake victims in the rebel-held northwest Syria.

On Sunday, World Health Organisation chief Tedros Adhanom Ghebreyesus said that Syrian President Bashar al-Assad is open for more border crossings so that aid can be reached to the quake victims in the rebel-held northwest Syria. Ghebreyesus held talks with the Syrian president in Damascus as the two discussed the response to the Turkey-Syria earthquake. "The compounding crises of conflict, Covid, cholera, economic decline and now the earthquake have taken an unbearable toll," said Tedros after he visited Aleppo and saw the devastation. ALSO READ | UN acknowledges relief failure in Syria as earthquake toll reaches 33,000 He said he was "waiting to move across lines to the northwest, where we've been told the impact is even worse". The situation has worsened in the rebel-held areas where aid convoys cannot reach the country's government-held without the authorisation of Damascus. The single border crossing which was open for the transfer of aid was also disrupted by the earthquake. "This afternoon I met with President Assad, who indicated he was open to considering additional cross-border access points for this emergency," said Tedros. during a virtual press conference from the Syrian capital. Tedros appreciated the "recent blanket approval by the government of Syria for the UN for cross-line conveys" to transfer aid into the rebel-held areas. However, he added that although cross-line aid convoys have been given the all-clear by Damascus to enter government-held areas, WHO is still waiting for the green light. "We're on standby," he said. WATCH | Syria allows aid delivery to rebel-hit areas WHO's director for the Eastern Mediterranean region Richard Brennan said that there had been "no cross-line deliveries since the earthquake struck". "We did have one scheduled in the next couple of days. We are still negotiating for that to go ahead," he added. (With inputs from agencies) You can now write for wionews.com and be a part of the community. Share your stories and opinions with us here. WATCH WION LIVE HERE

Syrian President Assad may allow more border crossings for transfer of aid, says WHO

According to an early draft of a global pandemic agreement, World Health Organization (WHO) may ask governments to reserve drugs and vaccines in order to distribute them in poorer countries. This step could be taken to avoid a repeat of the 'catastrophic failure' during the COVID-19 pandemic.&nbsp;According to Reuters, one of the most concrete proposals in the draft accord includes a measure to reserve 20 per cent of any tests, vaccines or treatments developed for use in poorer countries.

The draft also hints at reigniting an argument over intellectual property rights (IPRs) on vaccine formula. The draft says that it might ask countries to waive off IPRs on vaccines and life-saving drugs during pandemics to allow them wider access. Though the pharmaceutical industry is against the move.

Also Read |&nbsp;<a href="https://www.wionews.com/trending/zoo-chief-accused-of-killing-4-goats-for-christmas-party-trading-off-a-zebra-to-buy-tools-558137">Zoo chief accused of killing 4 goats for Christmas party, trading off a Zebra to buy ‘tools’</a>

The draft also retains earlier provisions that could see pharmaceutical companies made to release details of any public contracts for vaccines and treatments during such global health emergencies.

The agreement is known as the Pandemic Treaty which has been drawn by WHO members and will now go through a lengthy negotiating process before being finalised. The talks around the draft treaty will begin on February 27 and will continue till 2024. Member states have agreed that the treaty will be legally binding for those who sign up, but it is not clear how will it be enforced.&nbsp;

The above-mentioned draft was released on Wednesday to all member states and non-governmental organisations and contains numerous measures to ensure the world's response that the next pandemic is not only robust but more equitable.&nbsp;

"It is a once-in-a-generation chance to make a paradigm shift in the protection and improvement of the health of the world's people,"&nbsp;WHO spokesperson Fadela Chaib said of the accord.

The draft begins by saying it is being drawn up "in recognition of the catastrophic failure of the international community in showing solidarity and equity in response to the coronavirus disease (COVID-19) pandemic".

Watch |&nbsp;Potential vaccine breakthroughs in 2023

<div class="ui-state-default" contenteditable="false">
<div class="twitter-block" draggable="false">
<div class="videoWrapper trancodeVideo"><iframe allowfullscreen="" autoplay="1" class="includeVideo" frameborder="0" height="350" src="https://www.wionews.com/videos/gravitas-potential-vaccine-breakthroughs-in-2023-548192/embed" style="width:100%;max-width:560px;" width="560"></iframe></div>
</div>
<a class="close-mark close-div" href="#" id="jqclosemark">×</a></div>

"The 'accord' should build on the private sector's strengths for innovative R&amp;D, quick manufacturing scaling up and distribution, which is built on a robust intellectual property system," said Thomas Cueni, director general of the International Federation of Pharmaceutical Manufacturers and Associations.

The draft also features a new WHO Global Pandemic Supply Chain and Logistics Network to ensure better and more fair distribution of counter-measures.

It also proposes the WHO Pathogen Access and Benefit-Sharing System, which urges countries to share pathogens and genomic sequences "within hours".

Diagnostics, treatments and vaccines developed from the data should be shared fairly, including a provision that the WHO gets 20 per cent of any production, 10 per cent&nbsp;as a donation and the rest at affordable prices, for use in developing countries, the document suggests.

(With inputs from agencies)

&nbsp;

WATCH WION LIVE HERE

<iframe allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen="" frameborder="0" height="350" loading="”lazy”" src="https://www.wionews.com/live-tv/embed?autoplay=1&amp;mute=1" width="100%"></iframe>

You can now write for wionews.com and be a part of the community. Share your stories and opinions with us <a href="https://www.wionews.com/content-contribution-registration-form">here</a>.

&nbsp;

According to an early draft of a global pandemic agreement, World Health Organization (WHO) may ask governments to reserve drugs and vaccines in order to distribute them in poorer countries.

According to an early draft of a global pandemic agreement, World Health Organization (WHO) may ask governments to reserve drugs and vaccines in order to distribute them in poorer countries. This step could be taken to avoid a repeat of the 'catastrophic failure' during the COVID-19 pandemic. According to Reuters, one of the most concrete proposals in the draft accord includes a measure to reserve 20 per cent of any tests, vaccines or treatments developed for use in poorer countries. The draft also hints at reigniting an argument over intellectual property rights (IPRs) on vaccine formula. The draft says that it might ask countries to waive off IPRs on vaccines and life-saving drugs during pandemics to allow them wider access. Though the pharmaceutical industry is against the move. Also Read | Zoo chief accused of killing 4 goats for Christmas party, trading off a Zebra to buy ‘tools’ The draft also retains earlier provisions that could see pharmaceutical companies made to release details of any public contracts for vaccines and treatments during such global health emergencies. The agreement is known as the Pandemic Treaty which has been drawn by WHO members and will now go through a lengthy negotiating process before being finalised. The talks around the draft treaty will begin on February 27 and will continue till 2024. Member states have agreed that the treaty will be legally binding for those who sign up, but it is not clear how will it be enforced. The above-mentioned draft was released on Wednesday to all member states and non-governmental organisations and contains numerous measures to ensure the world's response that the next pandemic is not only robust but more equitable. "It is a once-in-a-generation chance to make a paradigm shift in the protection and improvement of the health of the world's people," WHO spokesperson Fadela Chaib said of the accord. The draft begins by saying it is being drawn up "in recognition of the catastrophic failure of the international community in showing solidarity and equity in response to the coronavirus disease (COVID-19) pandemic". Watch | Potential vaccine breakthroughs in 2023 × "The 'accord' should build on the private sector's strengths for innovative R&D, quick manufacturing scaling up and distribution, which is built on a robust intellectual property system," said Thomas Cueni, director general of the International Federation of Pharmaceutical Manufacturers and Associations. The draft also features a new WHO Global Pandemic Supply Chain and Logistics Network to ensure better and more fair distribution of counter-measures. It also proposes the WHO Pathogen Access and Benefit-Sharing System, which urges countries to share pathogens and genomic sequences "within hours". Diagnostics, treatments and vaccines developed from the data should be shared fairly, including a provision that the WHO gets 20 per cent of any production, 10 per cent as a donation and the rest at affordable prices, for use in developing countries, the document suggests. (With inputs from agencies) WATCH WION LIVE HERE You can now write for wionews.com and be a part of the community. Share your stories and opinions with us here.

WHO may ask countries to reserve vaccines for poor to prevent ‘catastrophic failure’ like Covid

The World Health Organization on Monday called for “immediate and concerted action” towards contaminated medicines after&nbsp;children's deaths linked to cough syrups last year. The organisation said, “These contaminants are toxic chemicals used as industrial solvents and antifreeze agents that can be fatal even taken in small amounts, and should never be found in medicines.”

WHO said&nbsp;that in 2022, over 300 children under the age of five died of acute kidney injuries, associated with contaminated medicines in Uzbekistan, Indonesia and Gambia.&nbsp;

<a href="https://www.wionews.com/world/indian-cough-syrups-linked-to-uzbekistan-deaths-should-not-be-used-for-kids-says-who-551885">Also read |&nbsp;Indian cough syrups linked to kids’ deaths in Uzbekistan should not be used, says WHO</a>

It told Reuters that the Philippines, Timor Leste, Senegal and Cambodia might also be affected because they still have the medicines on sale. It has also urged&nbsp;for action across its 194 member states to prevent deaths.&nbsp;

“Since these are not isolated incidents, WHO calls on various key stakeholders engaged in the medical supply chain to take immediate and coordinated action.”

It said that the over-the-counter-cough syrups had high levels of diethylene glycol and ethylene glycol.&nbsp;

<a href="https://www.wionews.com//world/uzbekistan-four-arrested-over-indian-made-cough-syrup-deaths-550023">Also read |&nbsp;Uzbekistan: Four arrested over Indian-made cough syrup deaths</a>

The WHO already sent specific product alerts in October 2022 and earlier this month, asking to remove these medicines made by India’s Maiden Pharmaceuticals and Marion biotech, which are linked to deaths in Gambia and Uzbekistan.&nbsp;

It also issued a warning last year for cough syrups made by four Indonesian manufacturers that were sold domestically. The manufacturers include PT Yarindo Farmatama, PT Universal Pharmaceutical, PT Konimex and PT AFI Pharma.

It urged the governments and regulators to assign resources to inspect manufacturers, increase market surveillance and take necessary actions.&nbsp;

(With inputs from agencies)

WATCH WION LIVE HERE

<iframe allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen="" frameborder="0" height="350" loading="”lazy”" src="https://www.wionews.com/live-tv/embed?autoplay=1&amp;mute=1" width="100%"></iframe>

The World Health Organization on Monday called for “immediate and concerted action” towards contaminated medicines after children's deaths linked to cough syrups last year.

The World Health Organization on Monday called for “immediate and concerted action” towards contaminated medicines after children's deaths linked to cough syrups last year. The organisation said, “These contaminants are toxic chemicals used as industrial solvents and antifreeze agents that can be fatal even taken in small amounts, and should never be found in medicines.” WHO said that in 2022, over 300 children under the age of five died of acute kidney injuries, associated with contaminated medicines in Uzbekistan, Indonesia and Gambia. Also read | Indian cough syrups linked to kids’ deaths in Uzbekistan should not be used, says WHO It told Reuters that the Philippines, Timor Leste, Senegal and Cambodia might also be affected because they still have the medicines on sale. It has also urged for action across its 194 member states to prevent deaths. “Since these are not isolated incidents, WHO calls on various key stakeholders engaged in the medical supply chain to take immediate and coordinated action.” It said that the over-the-counter-cough syrups had high levels of diethylene glycol and ethylene glycol. Also read | Uzbekistan: Four arrested over Indian-made cough syrup deaths The WHO already sent specific product alerts in October 2022 and earlier this month, asking to remove these medicines made by India’s Maiden Pharmaceuticals and Marion biotech, which are linked to deaths in Gambia and Uzbekistan. It also issued a warning last year for cough syrups made by four Indonesian manufacturers that were sold domestically. The manufacturers include PT Yarindo Farmatama, PT Universal Pharmaceutical, PT Konimex and PT AFI Pharma. It urged the governments and regulators to assign resources to inspect manufacturers, increase market surveillance and take necessary actions. (With inputs from agencies) WATCH WION LIVE HERE

WHO calls for immediate, concerted actions on contaminated medicines linked to over 300 kids' deaths

Taking note of the deaths of over 300 children linked to cough syrups in three countries, the World Health Organisation (WHO) has decided to launch a probe to find whether these medicines were contaminated from the manufacturers’ end, Reuters news agency reported citing sources familiar with the matter.&nbsp;

According to reports, the WHO found “unacceptable” level of toxins in these syrups and is seeking more information on the raw materials used by these six manufacturers in India and Indonesia.&nbsp;

More than 300 kids, mainly aged under 5, in Indonesia, Uzbekistan and Gambia died of acute kidney injury after consuming cough syrups, the WHO said in a statement on Monday.&nbsp;

The cough syrups were found to have had high levels of diethylene glycol and ethylene glycol.&nbsp;The WHO is probing whether the companies procured them from the same suppliers.&nbsp;No suppliers have been named.&nbsp;

<h2>WHO labels four cough syrups as 'substandard products; Indian pharmaceutical company in the dock?</h2>

<div class="videoWrapper trancodeVideo"><iframe allowfullscreen="" autoplay="1" class="includeVideo" frameborder="0" height="350" src="https://www.wionews.com/videos/who-labels-four-cough-syrups-as-substandard-products-indian-pharmaceutical-company-in-the-dock-523024/embed" style="width:100%;max-width:560px;" width="560"></iframe></div>

“These contaminants are toxic chemicals used as industrial solvents and antifreeze agents that can be fatal even taken in small amounts, and should never be found in medicines,” the WHO said.&nbsp;

According to Reuters, the WHO has alerted the Philippines, Timor Leste, Senegal, and Cambodia where the same products may have been on sale.&nbsp;It also called for action across its 194 member states to prevent more deaths.&nbsp;

“Since these are not isolated incidents, WHO calls on various key stakeholders engaged in the medical supply chain to take immediate and coordinated action,” the WHO said.&nbsp;

In October and earlier this month, the global health agency had already issued alerts asking for the removal of cough syrups from the shelves which are made by India’s Maiden Pharmaceuticals and Marion Biotech—both of whom are linked with deaths in the Gambia and Uzbekistan respectively.

It also issued a warning last year for cough syrups made by four Indonesian manufacturers, PT Yarindo Farmatama, PT Universal Pharmaceutical, PT Konimex and PT AFI Pharma, that were sold domestically, according to Reuters.

(With inputs from agencies)&nbsp;

WATCH WION LIVE HERE: 

<iframe allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen="" frameborder="0" height="350" loading="”lazy”" src="https://www.wionews.com/live-tv/embed?autoplay=1&amp;mute=1" width="100%"></iframe>

Taking note of the deaths of over 300 children linked to cough syrups in three countries, the World Health Organisation (WHO) has decided to launch a probe to find whether these medicines were contaminated from the manufacturers’ end, Reuters news agency reported citing sources familiar with the matter.

Taking note of the deaths of over 300 children linked to cough syrups in three countries, the World Health Organisation (WHO) has decided to launch a probe to find whether these medicines were contaminated from the manufacturers’ end, Reuters news agency reported citing sources familiar with the matter. According to reports, the WHO found “unacceptable” level of toxins in these syrups and is seeking more information on the raw materials used by these six manufacturers in India and Indonesia. More than 300 kids, mainly aged under 5, in Indonesia, Uzbekistan and Gambia died of acute kidney injury after consuming cough syrups, the WHO said in a statement on Monday. The cough syrups were found to have had high levels of diethylene glycol and ethylene glycol. The WHO is probing whether the companies procured them from the same suppliers. No suppliers have been named. WHO labels four cough syrups as 'substandard products; Indian pharmaceutical company in the dock? “These contaminants are toxic chemicals used as industrial solvents and antifreeze agents that can be fatal even taken in small amounts, and should never be found in medicines,” the WHO said. According to Reuters, the WHO has alerted the Philippines, Timor Leste, Senegal, and Cambodia where the same products may have been on sale. It also called for action across its 194 member states to prevent more deaths. “Since these are not isolated incidents, WHO calls on various key stakeholders engaged in the medical supply chain to take immediate and coordinated action,” the WHO said. In October and earlier this month, the global health agency had already issued alerts asking for the removal of cough syrups from the shelves which are made by India’s Maiden Pharmaceuticals and Marion Biotech—both of whom are linked with deaths in the Gambia and Uzbekistan respectively. It also issued a warning last year for cough syrups made by four Indonesian manufacturers, PT Yarindo Farmatama, PT Universal Pharmaceutical, PT Konimex and PT AFI Pharma, that were sold domestically, according to Reuters. (With inputs from agencies) WATCH WION LIVE HERE:

WHO to probe Indian, Indonesian firms over cough syrup linked deaths: Report 

The World Health Organization (WHO) said on Monday (January 23) that over five billion people are exposed to higher risks of heart diseases because of trans fats. The world health body has slammed the nations which have not taken appropriate actions to address the issue and act against the toxic substance.&nbsp;

Experts have said that the consumption of trans fat increases blood cholesterol levels and the risk of heart disease. Trans fat is a type of fat that has certain chemical properties. It is usually found in processed foods such as baked goods, snack foods, fried foods, etc. As reported, eating trans fats is responsible for up to 500,000 premature deaths from coronary heart disease each year around the world.&nbsp;

In 2018, WHO came up with the elimination of industrially produced trans fat globally. The target was set for 2023. Since its first call, the population coverage of best-practice policies has increased almost six-fold.&nbsp;

ALSO READ |&nbsp;<a href="https://www.wionews.com/world/corrosion-damage-to-infra-eats-up-to-5-of-global-gdp-says-report-experts-suggest-solutions-555185">Corrosion damage to infra eats up to 5% of global GDP, says report; experts suggest solutions</a>&nbsp;

WHO stated that 43 countries with combined populations of 2.8 billion people have implemented best-practice policies for tackling trans fat in food.&nbsp;

But more needs to be done as despite efforts, five billion are left worldwide at risk from trans fats' health impacts. The report also mentioned that the global goal for its total elimination in 2023 remains unattainable at this time.&nbsp;

<div class="ui-state-default" contenteditable="false">
<div class="twitter-block" draggable="false">
<blockquote class="twitter-tweet">
To eliminate <a href="https://twitter.com/hashtag/transfat?src=hash&amp;ref_src=twsrc%5Etfw">#transfat</a>, WHO recommends countries to 
 
❌ limit industrially produced trans fat to 2 grams/100 grams of total fat in all foods 
or 
❌ ban the production/use of partially hydrogenated oils as an ingredient in all foods. 
 
WHO new status report 👉<a href="https://t.co/gcvZ3Q4jO6">https://t.co/gcvZ3Q4jO6</a> <a href="https://t.co/MtBptcD6m4">pic.twitter.com/MtBptcD6m4</a>
— World Health Organization (WHO) (@WHO) <a href="https://twitter.com/WHO/status/1617459468882657282?ref_src=twsrc%5Etfw">January 23, 2023</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
<a class="close-mark close-div" href="#" id="jqclosemark">×</a></div>

WATCH |&nbsp;WION Climate Tracker: Climate crisis threatens Australia's Queensland&nbsp;

<div class="ui-state-default" contenteditable="false">
<div class="twitter-block" draggable="false">
<div class="videoWrapper trancodeVideo"><iframe allowfullscreen="" autoplay="1" class="includeVideo" frameborder="0" height="350" src="https://www.wionews.com/videos/wion-climate-tracker-climate-crisis-threatens-australias-queensland-555250/embed" style="width:100%;max-width:560px;" width="560"></iframe></div>
</div>
<a class="close-mark close-div" href="#" id="jqclosemark">×</a></div>

WHO Director-General, Dr Tedros Adhanom Ghebreyesus said, "Trans fat has no known benefit and huge health risks that incur huge costs for health systems."&nbsp;

"By contrast, eliminating trans fat is cost-effective and has enormous benefits for health. Put simply, trans fat is a toxic chemical that kills and should have no place in food. It’s time to get rid of it once and for all," the WHO chief added.&nbsp;

WHO said that nine of the 16 countries currently with the highest estimated proportion of coronary heart disease deaths caused by trans fat intake do not have a best-practice policy. Such nations are Australia, Azerbaijan, Bhutan, Ecuador, Egypt, Iran, Nepal, Pakistan and South Korea.&nbsp;

(With inputs from agencies)&nbsp;

WATCH WION LIVE HERE

<iframe allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen="" frameborder="0" height="350" loading="”lazy”" src="https://www.wionews.com/live-tv/embed?autoplay=1&amp;mute=1" width="100%"></iframe>

You can now write for wionews.com and be a part of the community. Share your stories and opinions with us <a href="https://www.wionews.com/content-contribution-registration-form">here</a>.

The World Health Organization (WHO) said on Monday (January 23) that over five billion people are exposed to higher risks of heart diseases because of trans fats.

The World Health Organization (WHO) said on Monday (January 23) that over five billion people are exposed to higher risks of heart diseases because of trans fats. The world health body has slammed the nations which have not taken appropriate actions to address the issue and act against the toxic substance. Experts have said that the consumption of trans fat increases blood cholesterol levels and the risk of heart disease. Trans fat is a type of fat that has certain chemical properties. It is usually found in processed foods such as baked goods, snack foods, fried foods, etc. As reported, eating trans fats is responsible for up to 500,000 premature deaths from coronary heart disease each year around the world. In 2018, WHO came up with the elimination of industrially produced trans fat globally. The target was set for 2023. Since its first call, the population coverage of best-practice policies has increased almost six-fold. ALSO READ | Corrosion damage to infra eats up to 5% of global GDP, says report; experts suggest solutions WHO stated that 43 countries with combined populations of 2.8 billion people have implemented best-practice policies for tackling trans fat in food. But more needs to be done as despite efforts, five billion are left worldwide at risk from trans fats' health impacts. The report also mentioned that the global goal for its total elimination in 2023 remains unattainable at this time. To eliminate #transfat, WHO recommends countries to ❌ limit industrially produced trans fat to 2 grams/100 grams of total fat in all foods or ❌ ban the production/use of partially hydrogenated oils as an ingredient in all foods. WHO new status report 👉https://t.co/gcvZ3Q4jO6 pic.twitter.com/MtBptcD6m4 — World Health Organization (WHO) (@WHO) January 23, 2023 × WATCH | WION Climate Tracker: Climate crisis threatens Australia's Queensland × WHO Director-General, Dr Tedros Adhanom Ghebreyesus said, "Trans fat has no known benefit and huge health risks that incur huge costs for health systems." "By contrast, eliminating trans fat is cost-effective and has enormous benefits for health. Put simply, trans fat is a toxic chemical that kills and should have no place in food. It’s time to get rid of it once and for all," the WHO chief added. WHO said that nine of the 16 countries currently with the highest estimated proportion of coronary heart disease deaths caused by trans fat intake do not have a best-practice policy. Such nations are Australia, Azerbaijan, Bhutan, Ecuador, Egypt, Iran, Nepal, Pakistan and South Korea. (With inputs from agencies) WATCH WION LIVE HERE You can now write for wionews.com and be a part of the community. Share your stories and opinions with us here.

WHO says over five billion people still exposed to trans fats' devastating health impacts

Let's take a look at what is trending on WION's social platform - Citizens astonished after lens cloud in shape of UFO appears in Turkiye's sky, Instagram rolls out 'quiet mode'; enhances parental supervision for teens, Alabama man secretly paid pharmacy for others, WHO says China reports big jump in hospitalisations by 70%.

Trending on WION: China takes down rabbit lantern as internet finds it 'ugly'

The World Health Organisation (WHO) said on Thursday (January 19) that China reported a 70% rise in weekly Covid hospitalisations, the highest since the pandemic started. According to the WHO's report based on data submitted by Beijing, the number of people hospitalised rose by 70 % to 63,307 versus the previous week, news agency Reuters reported. However, the United Nations health agency said it was awaiting "detailed provincial data disaggregated by week of reporting" on nearly 60,000 virus-related hospital deaths reported by China last week and did not include them in the tally.

A few days back, the WHO had urged China to share more information on the pandemic and said it will continue to work with the government providing technical advice and support, and engaging in analysing the situation.

ALSO READ |&nbsp;<a data-loopstyle="link" href="https://www.wionews.com/world/china-announces-censorship-crackdown-to-get-rid-of-covid-rumours-on-internet-554148">China announces censorship crackdown to remove Covid ‘rumours’&nbsp;</a>

Thursday's development comes as Beijing said that the worst was over in its battle against Covid ahead of the Lunar New Year celebrations. Vice Premier Sun Chunlan, who oversees the country's virus response, said on Thursday the outbreak was at a "relatively low" level. Chunlan's comment comes after health officials said the number of virus patients in clinics, emergency rooms and with critical conditions had peaked.

Zhang Xiangyang, the director of the emergency department at the Beijing Tsinghua Changgeng Hospital told CCTV on Thursday that since mid-December last year, the number of patients received at the ER increased by two to three folds. The CCTV report said that Zhang's department received over 70 Covid patients in critical condition in just one day on January 8, whose average age was over 70 years. Of these, more than 10 recovered and were discharged over the past 10 days, the report added.&nbsp;

South Korea to lift mask mandate for indoor public places from Jan 30

South Korean Prime Minister Han Duck-soo said on Friday (January 20) that the government will lift the face mask mandate for most indoor public places from January 30, becoming the latest step to ease Covid rules in the country. However, Prime Minister Duck-soo still recommended that people should keep their faces covered and pointed out that masks will still be required on transport and in medical facilities. During a Covid response meeting, he said, "The daily number of new infections is continuing to decline and despite concerns over a spike in cases in China, the situation here is under control without major troubles," news agency Reuters reported.&nbsp;

The dropping of the mask mandate for public places comes as South Koreans will mark the Lunar Year Holidays during which they will travel to their home towns. Prime Minister Duck-soo also warned during Friday's meeting that the easing of mask rules could cause a temporary surge in new Covid infections, urging health authorities to stay vigilant, especially to those who are more vulnerable to the virus.&nbsp;

ALSO READ |&nbsp;<a data-loopstyle="link" href="https://www.wionews.com/world/around-500-people-evacuated-as-massive-blaze-engulfs-south-korean-slum-554291">Around 500 people evacuated as massive blaze engulfs South Korean slum</a>

Since the onset of the pandemic, South Korea has recorded more than 29.9 million infections and 33,104 deaths, according to data from the World Health Organization (WHO). The government has scrapped most of the Covid-related curbs including dropping the outdoor mask rule in May last year, but it maintains a seven-day isolation for people testing positive for the virus.&nbsp;

Additionally, the South Korean government requires that travellers from China, Macau and Hong Kong should provide a negative Covid test result before departure. As a retaliation,&nbsp;<a data-loopstyle="link" href="https://www.wionews.com/east-asia/covid-19-curbs-japan-protests-over-citizens-visa-suspension-china-defends-retaliation-551384">China suspended issuing short-term visas</a>&nbsp;in South Korea. The Chinese embassy in Seoul suspended issuing short-term visas for South Korean visitors on January 10. Taking to WeChat, the embassy said it would adjust the policy subject to the lifting of South Korea's "discriminatory entry restrictions" against Beijing.&nbsp;

ALSO READ |&nbsp;<a data-loopstyle="link" href="https://www.wionews.com/world/south-korea-halloween-stampede-cops-blame-fatal-crush-on-negligence-552279">South Korea Halloween crowd crush: Cops blame negligence for fatal incident</a>

South Korea's foreign minister &nbsp;Park Jin said on January 11 that the visa suspension was deeply regrettable while highlighting that Seoul still issues visas to Chinese visitors with urgent requests. "It's deeply regrettable that China took such a countermeasure by entirely suspending issuance of short-term visas. We make exceptions and issue visas for diplomatic, work, urgent business or humanitarian purposes," Jin told reporters, according to an earlier Reuters report.&nbsp;

(With inputs from agencies)

WATCH WION LIVE HERE

<iframe allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen="" frameborder="0" height="350" loading="”lazy”" src="https://www.wionews.com/live-tv/embed?autoplay=1&amp;mute=1  width=&quot;100%&quot;"></iframe>

You can now write for wionews.com and be a part of the community. Share your stories and opinions with us <a href="https://www.wionews.com/content-contribution-registration-form">here</a>.

The World Health Organisation (WHO) said on Thursday (January 19) that China reported a 70% rise in weekly Covid hospitalisations, the highest since the pandemic started.

The World Health Organisation (WHO) said on Thursday (January 19) that China reported a 70% rise in weekly Covid hospitalisations, the highest since the pandemic started. According to the WHO's report based on data submitted by Beijing, the number of people hospitalised rose by 70 % to 63,307 versus the previous week, news agency Reuters reported. However, the United Nations health agency said it was awaiting "detailed provincial data disaggregated by week of reporting" on nearly 60,000 virus-related hospital deaths reported by China last week and did not include them in the tally. A few days back, the WHO had urged China to share more information on the pandemic and said it will continue to work with the government providing technical advice and support, and engaging in analysing the situation. ALSO READ | China announces censorship crackdown to remove Covid ‘rumours’ Thursday's development comes as Beijing said that the worst was over in its battle against Covid ahead of the Lunar New Year celebrations. Vice Premier Sun Chunlan, who oversees the country's virus response, said on Thursday the outbreak was at a "relatively low" level. Chunlan's comment comes after health officials said the number of virus patients in clinics, emergency rooms and with critical conditions had peaked. Zhang Xiangyang, the director of the emergency department at the Beijing Tsinghua Changgeng Hospital told CCTV on Thursday that since mid-December last year, the number of patients received at the ER increased by two to three folds. The CCTV report said that Zhang's department received over 70 Covid patients in critical condition in just one day on January 8, whose average age was over 70 years. Of these, more than 10 recovered and were discharged over the past 10 days, the report added. South Korea to lift mask mandate for indoor public places from Jan 30 South Korean Prime Minister Han Duck-soo said on Friday (January 20) that the government will lift the face mask mandate for most indoor public places from January 30, becoming the latest step to ease Covid rules in the country. However, Prime Minister Duck-soo still recommended that people should keep their faces covered and pointed out that masks will still be required on transport and in medical facilities. During a Covid response meeting, he said, "The daily number of new infections is continuing to decline and despite concerns over a spike in cases in China, the situation here is under control without major troubles," news agency Reuters reported. The dropping of the mask mandate for public places comes as South Koreans will mark the Lunar Year Holidays during which they will travel to their home towns. Prime Minister Duck-soo also warned during Friday's meeting that the easing of mask rules could cause a temporary surge in new Covid infections, urging health authorities to stay vigilant, especially to those who are more vulnerable to the virus. ALSO READ | Around 500 people evacuated as massive blaze engulfs South Korean slum Since the onset of the pandemic, South Korea has recorded more than 29.9 million infections and 33,104 deaths, according to data from the World Health Organization (WHO). The government has scrapped most of the Covid-related curbs including dropping the outdoor mask rule in May last year, but it maintains a seven-day isolation for people testing positive for the virus. Additionally, the South Korean government requires that travellers from China, Macau and Hong Kong should provide a negative Covid test result before departure. As a retaliation, China suspended issuing short-term visas in South Korea. The Chinese embassy in Seoul suspended issuing short-term visas for South Korean visitors on January 10. Taking to WeChat, the embassy said it would adjust the policy subject to the lifting of South Korea's "discriminatory entry restrictions" against Beijing. ALSO READ | South Korea Halloween crowd crush: Cops blame negligence for fatal incident South Korea's foreign minister Park Jin said on January 11 that the visa suspension was deeply regrettable while highlighting that Seoul still issues visas to Chinese visitors with urgent requests. "It's deeply regrettable that China took such a countermeasure by entirely suspending issuance of short-term visas. We make exceptions and issue visas for diplomatic, work, urgent business or humanitarian purposes," Jin told reporters, according to an earlier Reuters report. (With inputs from agencies) WATCH WION LIVE HERE You can now write for wionews.com and be a part of the community. Share your stories and opinions with us here.

Covid: China reports 70% rise in weekly hospitalisations, highest since pandemic began, says WHO

Addressing a session amid the ongoing World Economic Forum (WEF) Annual Meeting, 2023 in Davos, Switzerland on ‘Ending Tuberculosis’, the Indian Health Minister, Mansukh Mandaviya, said that New Delhi extends its full support for a global plan for approving a new TB vaccine by 2025. Similarly, the head of the World Health Organization (WHO), Tedros Adhanom Ghebreyesus also announced plans to speed up the licensing and use of novel vaccines against tuberculosis (TB) and the creation of the TB Vaccine Accelerator Council, on Tuesday (January 17).&nbsp;

“Just as vaccines were a game-changer in the battle against COVID, Global Plan calls for approving a new TB vaccine by 2025 and making it available to adults and adolescents in TB-affected nations,” said Mandaviya, as per PTI. He added, “India is fully prepared and in an advanced stage for taking this forward.” The Indian Health minister also noted how more than 1.6 million across the world lost their lives because of TB in 2021 and it was the leading cause of death from infectious diseases before the COVID-19 pandemic.&nbsp;

Initiatives taken by the Indian government&nbsp;to fight TB

The health minister also spoke about how under the leadership of Indian Prime Minister Narendra Modi the country has been at the forefront of the global fight against TB including the recently launched ‘Pradhan Mantri TB Mukt Bharat Abhiyan’. The campaign of community engagement aims to provide nutritional diagnostic and vocational support to TB patients delivered through the community, said Mandaviya.&nbsp;

ALSO WATCH |&nbsp;<a href="https://www.wionews.com/videos/south-asia-diary-after-covid-19-india-turns-to-tuberculosis-468381">South Asia Diary | After Covid-19, India turns to Tuberculosis</a>

The initiative has also already seen over 50,000 Ni-kshay Mitras adopting over 1.3 million TB patients, said the health minister. He added, “We have taken several initiatives to intensify case finding, ensure medicine supply including tele consultation services to every TB patient.” In 2021, the Modi government said they aim to eliminate TB from India by 2025.&nbsp;

<div class="ui-state-default" contenteditable="false">
<div class="twitter-block" draggable="false">
<blockquote class="twitter-tweet">
Just as vaccines were a game-changer 
in battle against COVID, Global Plan calls for approving a new TB vaccine by 2025 &amp; making it available to adults &amp; adolescents in TB-affected nations. 
 
🇮🇳 is fully prepared &amp; in an advanced stage for taking this forward: Dr <a href="https://twitter.com/mansukhmandviya?ref_src=twsrc%5Etfw">@MansukhMandviya</a>
— Office of Dr Mansukh Mandaviya (@OfficeOf_MM) <a href="https://twitter.com/OfficeOf_MM/status/1615370942947151872?ref_src=twsrc%5Etfw">January 17, 2023</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
<a class="close-mark close-div" href="#" id="jqclosemark">×</a></div>

The Indian health minister who is also the Chair of the ‘Stop TB Partnership Board’ said he has an additional responsibility towards TB management efforts globally. “Full implementation of the global plan developed by Stop TB Partnership requires US$250 billion over next 8 years, the equivalent of just US$4 per person, per year worldwide,” said Mandaviya.&nbsp;

This would deliver an economic return of US$40 for every dollar invested, the Indian health minister added. He also reiterated the importance of ensuring sufficient funds for the initiative as we would end up paying a much higher price later.&nbsp;

ALSO READ |&nbsp;<a href="https://www.wionews.com/india-news/pm-modi-to-inaugurate-delhi-end-tb-summit-today-35575">PM Modi to inaugurate Delhi End TB Summit today</a>

WHO launches ‘TB Vaccine Accelerator Council’&nbsp;

Director-General of the WHO, Tedros also addressed the ongoing WEF in Davos and said, “The challenges presented by TB and COVID-19 are different, but the ingredients that accelerate science, research and innovation are the same: urgent, up-front public investment; support from philanthropy; and engagement of the private sector and communities.”&nbsp;

He also noted how one of the most important lessons from the COVID-19 response is that innovative health interventions can be delivered fast if they are prioritized politically and financed sufficiently. Therefore, in order to speed up the licensing and use of vaccines against TB Tedros announced the TB Vaccine Accelerator Council. The council will include funders, global agencies, governments and those with TB, in identifying and overcoming barriers to vaccine development, said the UN.

ALSO WATCH |&nbsp;<a href="https://www.wionews.com/videos/gravitas-is-tuberculosis-making-a-deadly-comeback-529263">Gravitas: Is Tuberculosis making a deadly comeback?&nbsp;</a>

As of today, there is only one licensed vaccine for TB which is the Bacillus Calmette-Guérin (BCG) vaccine, developed in 1921. Notably, no new TB vaccines have been licensed in a century despite how adversely the disease has impacted human health. According to the UN agency, TB remains the second leading infectious killer after COVID-19 and the 13th leading cause of death worldwide.&nbsp;

It is also both curable and preventable but even with global commitments to end the disease by 2030, the epidemic has shown no signs of slowing down, said WHO. In 2021, over 10 million people were infected with the disease. Additionally, the global health agency also noted, drug resistance continues to be a major problem with at least half a million people developing drug-resistant TB every year.&nbsp;

(With inputs from agencies)&nbsp; 
 
&nbsp;

WATCH WION LIVE HERE

<iframe allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen="" frameborder="0" height="350" loading="”lazy”" src="https://www.wionews.com/live-tv/embed?autoplay=1&amp;mute=1" width="100%"></iframe>

You can now write for wionews.com and be a part of the community. Share your stories and opinions with us <a href="https://www.wionews.com/content-contribution-registration-form">here</a>.

Addressing a session amid the ongoing World Economic Forum (WEF) Annual Meeting, 2023 in Davos, Switzerland on ‘Ending Tuberculosis’, the Indian Health Minister, Mansukh Mandaviya, said that New Delhi extends its full support for a global plan for approving a new TB vaccine by 2025.

Addressing a session amid the ongoing World Economic Forum (WEF) Annual Meeting, 2023 in Davos, Switzerland on ‘Ending Tuberculosis’, the Indian Health Minister, Mansukh Mandaviya, said that New Delhi extends its full support for a global plan for approving a new TB vaccine by 2025. Similarly, the head of the World Health Organization (WHO), Tedros Adhanom Ghebreyesus also announced plans to speed up the licensing and use of novel vaccines against tuberculosis (TB) and the creation of the TB Vaccine Accelerator Council, on Tuesday (January 17). “Just as vaccines were a game-changer in the battle against COVID, Global Plan calls for approving a new TB vaccine by 2025 and making it available to adults and adolescents in TB-affected nations,” said Mandaviya, as per PTI. He added, “India is fully prepared and in an advanced stage for taking this forward.” The Indian Health minister also noted how more than 1.6 million across the world lost their lives because of TB in 2021 and it was the leading cause of death from infectious diseases before the COVID-19 pandemic. Initiatives taken by the Indian government to fight TB The health minister also spoke about how under the leadership of Indian Prime Minister Narendra Modi the country has been at the forefront of the global fight against TB including the recently launched ‘Pradhan Mantri TB Mukt Bharat Abhiyan’. The campaign of community engagement aims to provide nutritional diagnostic and vocational support to TB patients delivered through the community, said Mandaviya. ALSO WATCH | South Asia Diary | After Covid-19, India turns to Tuberculosis The initiative has also already seen over 50,000 Ni-kshay Mitras adopting over 1.3 million TB patients, said the health minister. He added, “We have taken several initiatives to intensify case finding, ensure medicine supply including tele consultation services to every TB patient.” In 2021, the Modi government said they aim to eliminate TB from India by 2025. Just as vaccines were a game-changer in battle against COVID, Global Plan calls for approving a new TB vaccine by 2025 & making it available to adults & adolescents in TB-affected nations. 🇮🇳 is fully prepared & in an advanced stage for taking this forward: Dr @MansukhMandviya — Office of Dr Mansukh Mandaviya (@OfficeOf_MM) January 17, 2023 × The Indian health minister who is also the Chair of the ‘Stop TB Partnership Board’ said he has an additional responsibility towards TB management efforts globally. “Full implementation of the global plan developed by Stop TB Partnership requires US$250 billion over next 8 years, the equivalent of just US$4 per person, per year worldwide,” said Mandaviya. This would deliver an economic return of US$40 for every dollar invested, the Indian health minister added. He also reiterated the importance of ensuring sufficient funds for the initiative as we would end up paying a much higher price later. ALSO READ | PM Modi to inaugurate Delhi End TB Summit today WHO launches ‘TB Vaccine Accelerator Council’ Director-General of the WHO, Tedros also addressed the ongoing WEF in Davos and said, “The challenges presented by TB and COVID-19 are different, but the ingredients that accelerate science, research and innovation are the same: urgent, up-front public investment; support from philanthropy; and engagement of the private sector and communities.” He also noted how one of the most important lessons from the COVID-19 response is that innovative health interventions can be delivered fast if they are prioritized politically and financed sufficiently. Therefore, in order to speed up the licensing and use of vaccines against TB Tedros announced the TB Vaccine Accelerator Council. The council will include funders, global agencies, governments and those with TB, in identifying and overcoming barriers to vaccine development, said the UN. ALSO WATCH | Gravitas: Is Tuberculosis making a deadly comeback? As of today, there is only one licensed vaccine for TB which is the Bacillus Calmette-Guérin (BCG) vaccine, developed in 1921. Notably, no new TB vaccines have been licensed in a century despite how adversely the disease has impacted human health. According to the UN agency, TB remains the second leading infectious killer after COVID-19 and the 13th leading cause of death worldwide. It is also both curable and preventable but even with global commitments to end the disease by 2030, the epidemic has shown no signs of slowing down, said WHO. In 2021, over 10 million people were infected with the disease. Additionally, the global health agency also noted, drug resistance continues to be a major problem with at least half a million people developing drug-resistant TB every year. (With inputs from agencies) WATCH WION LIVE HERE You can now write for wionews.com and be a part of the community. Share your stories and opinions with us here.

India to deliver global plan for TB vaccines by 2025, says health minister

The World Health Organisation has stated that no amount of alcohol is safe for consumption. The WHO statement in The Lancet Public Health journal further added that alcohol causes seven types of cancer.&nbsp;Thus, the carcinogenic effects of alcohol can start at any threshold. No matter what portion of alcohol a person consumes, they are at risk of cancer.&nbsp;

The is no safe level of alcohol because no scientific evidence provides a mark when there is no risk of illness or injury. In 2020, alcohol caused 740,000 cases of cancer&nbsp;in the world, according to the Guardian.

Also Read|&nbsp;<a href="www.wionews.com/science/these-space-candle-stars-help-study-milky-ways-empty-reaches-551868">These 'space candle' stars help study Milky Way's empty reaches</a>

According to the International Agency for Research on Cancer, alcohol with asbestos, radiation, and tobacco are high-risk Group 1 carcinogens that contribute the most to cancer globally.

Alcohol causes seven kinds of cancer. Out of these, the most prominent ones are bowel cancer and female breast cancer. Moreover, alcohol directly connects to the oesophagus, liver, and colorectal cancers.&nbsp;

Watch |&nbsp;No amount of alcohol is safe to drink

<div class="videoWrapper trancodeVideo"><iframe allowfullscreen="" autoplay="1" class="includeVideo" frameborder="0" height="350" src="https://www.wionews.com/videos/no-amount-of-alcohol-is-safe-to-drink-552241/embed" style="width:100%;max-width:560px;" width="560"></iframe></div>

Any beverage that contains alcohol, despite the price, amount or quality, has a risk of causing cancer. Compounds break down in the body through multiple biological mechanisms during which alcohol can produce cancerous cells.

According to WHO, no studies prove the potential benefits of alcohol on cardiovascular diseases or type 2 diabetes. However, research says that people who drink 'booze' are more prone to cardiovascular diseases. Among alcohol consumers, the underprivileged strata of the global population are under more threat due to the quality of alcohol available.&nbsp;

In Europe, where cancer is the leading cause of death, light to medium intake of alcohol has led to 23,000 new cases in 2017. Among them, approximately 50 per cent were cases of female breast cancer. Nevertheless, Europe has the highest alcohol consumption level. Over 200 million people are at risk of having cancer caused by alcohol.&nbsp;

(With inputs from agencies)

WATCH WION LIVE HERE

<iframe allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen="" frameborder="0" height="350" loading="”lazy”" src="https://www.wionews.com/live-tv/embed?autoplay=1&amp;mute=1" width="100%"></iframe>

The World Health Organisation has stated that no amount of alcohol is safe for consumption. The WHO statement in The Lancet Public Health journal further added that alcohol causes seven types of cancer.

The World Health Organisation has stated that no amount of alcohol is safe for consumption. The WHO statement in The Lancet Public Health journal further added that alcohol causes seven types of cancer. Thus, the carcinogenic effects of alcohol can start at any threshold. No matter what portion of alcohol a person consumes, they are at risk of cancer. The is no safe level of alcohol because no scientific evidence provides a mark when there is no risk of illness or injury. In 2020, alcohol caused 740,000 cases of cancer in the world, according to the Guardian. Also Read| These 'space candle' stars help study Milky Way's empty reaches According to the International Agency for Research on Cancer, alcohol with asbestos, radiation, and tobacco are high-risk Group 1 carcinogens that contribute the most to cancer globally. Alcohol causes seven kinds of cancer. Out of these, the most prominent ones are bowel cancer and female breast cancer. Moreover, alcohol directly connects to the oesophagus, liver, and colorectal cancers. Watch | No amount of alcohol is safe to drink Any beverage that contains alcohol, despite the price, amount or quality, has a risk of causing cancer. Compounds break down in the body through multiple biological mechanisms during which alcohol can produce cancerous cells. According to WHO, no studies prove the potential benefits of alcohol on cardiovascular diseases or type 2 diabetes. However, research says that people who drink 'booze' are more prone to cardiovascular diseases. Among alcohol consumers, the underprivileged strata of the global population are under more threat due to the quality of alcohol available. In Europe, where cancer is the leading cause of death, light to medium intake of alcohol has led to 23,000 new cases in 2017. Among them, approximately 50 per cent were cases of female breast cancer. Nevertheless, Europe has the highest alcohol consumption level. Over 200 million people are at risk of having cancer caused by alcohol. (With inputs from agencies) WATCH WION LIVE HERE

No amount of alcohol intake ‘safe’, even low consumption has risk of cancer, warns WHO

As Covid rips through China, the World Health Organisation and several countries have voiced concern about data shared by China on deaths with satellite images on China's funeral facilities and hospitals telling an entire different story.

China fudging Covid data? WHO says country still underreports deaths

In today's news hundreds of residents evacuate India's sinking town 'Joshimath', WHO says China 'heavily underreporting' Covid deaths, China launches gold and silver coins.

Trending on WION: Disney to roll back theme park prices as CEO Iger attempts to woo visitors back

The World Health Organisation on Wednesday said that the cough syrups made by the&nbsp;pharmaceutical firm Marion Biotech based in India&nbsp;should not be used for children. The recommendation comes after the syrups were&nbsp;linked to the deaths of 19 children in Uzbekistan. Few claims were made after an analysis made by Uzbekistan's health ministry showed that the syrups, Ambronol and DOK-1 Max contained ethylene glycol, a toxic substance.&nbsp;

The ministry's analysis further added that syrups were given&nbsp;to children in high doses, either by their parents, who misunderstood it as an anti-cold remedy, or on the advice of pharmacists.&nbsp;

<a href="https://www.wionews.com/world/uzbekistan-four-arrested-over-indian-made-cough-syrup-deaths-550023">Also read |&nbsp;Uzbekistan: Four arrested over Indian-made cough syrup deaths</a>

The Indian ministry suspended the production of the syrup at the factory&nbsp;soon after the deaths of 19 children were reported in Uzbekistan. However, the state of Uttar Pradesh in north&nbsp;India&nbsp;has suspended the production licence of Marion&nbsp;Biotech, according to&nbsp;recent reports.&nbsp;

So far, Marion has not provided any evidence to WHO on the safety and quality of its products.&nbsp;

<a href="https://www.wionews.com/world/uzbekistan-syrup-deaths-who-says-its-in-touch-with-uzbek-authorities-548127">Also&nbsp;read |&nbsp;Uzbekistan cough syrup deaths: WHO says it's in touch with Uzbek authorities</a>

Recently, four people were arrested during an investigation into the cough syrup matter by Uzbekistan's state security service.&nbsp;

The Uzbekistan incident came to light after almost 70 children allegedly died&nbsp;in Gambia after consuming cough and cold syrup manufactured by Maiden Pharmaceuticals based in New Delhi. The company, though denied any wrongdoing in the matter, prompting investigations.&nbsp;

However, according to the data provided by the Indian government inspectors, no contamination was founded in the test samples taken from Maiden Pharmaceuticals.&nbsp;

(With inputs from agencies)

WATCH WION LIVE HERE

<iframe allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen="" frameborder="0" height="350" loading="”lazy”" src="https://www.wionews.com/live-tv/embed?autoplay=1&amp;mute=1" width="100%"></iframe>

The World Health Organisation on Wednesday said that the cough syrups made by the pharmaceutical firm Marion Biotech based in India should not be used for children.

The World Health Organisation on Wednesday said that the cough syrups made by the pharmaceutical firm Marion Biotech based in India should not be used for children. The recommendation comes after the syrups were linked to the deaths of 19 children in Uzbekistan. Few claims were made after an analysis made by Uzbekistan's health ministry showed that the syrups, Ambronol and DOK-1 Max contained ethylene glycol, a toxic substance. The ministry's analysis further added that syrups were given to children in high doses, either by their parents, who misunderstood it as an anti-cold remedy, or on the advice of pharmacists. Also read | Uzbekistan: Four arrested over Indian-made cough syrup deaths The Indian ministry suspended the production of the syrup at the factory soon after the deaths of 19 children were reported in Uzbekistan. However, the state of Uttar Pradesh in north India has suspended the production licence of Marion Biotech, according to recent reports. So far, Marion has not provided any evidence to WHO on the safety and quality of its products. Also read | Uzbekistan cough syrup deaths: WHO says it's in touch with Uzbek authorities Recently, four people were arrested during an investigation into the cough syrup matter by Uzbekistan's state security service. The Uzbekistan incident came to light after almost 70 children allegedly died in Gambia after consuming cough and cold syrup manufactured by Maiden Pharmaceuticals based in New Delhi. The company, though denied any wrongdoing in the matter, prompting investigations. However, according to the data provided by the Indian government inspectors, no contamination was founded in the test samples taken from Maiden Pharmaceuticals. (With inputs from agencies) WATCH WION LIVE HERE

Indian cough syrups linked to kids’ deaths in Uzbekistan should not be used, says WHO

Dr. Hans Kluge, World Health Organization's Europe director, calls for precautionary travel restrictions linked to passengers coming from China "to be rooted in science, proportionate and non-discriminatory"

WHO: Measures for travel from China should be 'non discriminatory'

It's almost ironical, given how the W.H.O. has seemingly been party to China's cover-up. Priyanka Sharma tells you.

Gravitas: W.H.O. pulls up China for undercounting Wuhan virus deaths

The World Health Organisation says that China has been hiding the real extent of Covid, something that the world has been saying while Beijing all along has been maintaining that all is well. The statemate was made by WHO after meeting Chinese officials.

WHO concerned about risk to life in China, asks for reliable data on hospitalisations, deaths

The World Health Organisation (WHO) criticised China for the “very narrow” definition of COVID-19 deaths and said that the government has not revealed the true impact of the new infections.&nbsp;"We believe that the current numbers being published from China under-represent the true impact of the disease in terms of hospital admissions, in terms of ICU admissions, and particularly in terms of deaths," the WHO's emergencies director Michael Ryan told reporters.

Earlier, WHO&nbsp;officials met with a team of Chinese scientists on Tuesday in order to verify the accuracy of China’s COVID-19 data and the latest growth in infections, said an AFP report. The Communist Party of China’s mouthpiece newspaper claimed on Wednesday that the country is pushing for a “final victory” over the pandemic but the numbers are telling a completely different story.

The number of Covid cases skyrocketed after relaxation of restrictions in China and in the past few weeks, the hospitals in various parts of the country have been full with patients of all ages.

Also read |&nbsp;<a href="https://www.wionews.com/world/omicron-offshoot-to-xbb15-may-cause-new-covid-spike-in-the-us-confirms-cdc-549368">Omicron offshoot XBB.1.5 may cause new Covid spike in the US, confirms CDC</a>

The United Nations has already asked the scientists in China to submit independent data in order to get a clear picture of the situation in China. According to Reuters, the WHO has not received any data from China regarding the COVID-19 cases since the shift in policy by the Chinese government.

Chinese President Xi Jinping implemented the strict Zero Covid policy in an attempt to control the infection but in the face of nationwide protests, the government decided to relax some restrictions.

WATCH |&nbsp;China: Covid-19 cases on the rise, WHO urges to share real-time data

<div class="videoWrapper trancodeVideo"><iframe allowfullscreen="" autoplay="1" class="includeVideo" frameborder="0" height="350" src="https://www.wionews.com/videos/china-covid-19-cases-on-the-rise-who-urges-to-share-real-time-data-548381/embed" style="width:100%;max-width:560px;" width="560"></iframe></div>

According to local media reports, China had just five deaths related to Covid and around 5258 infections. That is a number which is lesser than the average toll seen in the last six months.

The strict restrictions also had a massive impact on the Chinese economy which is currently valued at $17 trillion. However, with the economy opening up, the Chinese yuan is currently going at a four-month high against the United States Dollar as the manufacturing units also resumed operations. 
 
(With inputs from agencies)

<iframe allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen="" frameborder="0" height="350" loading="”lazy”" src="https://www.wionews.com/live-tv/embed?autoplay=1&amp;mute=1" width="100%"></iframe>

The World Health Organisation (WHO) criticised China for the “very narrow” definition of COVID-19 deaths and said that the government has not revealed the true impact of the new infections.

The World Health Organisation (WHO) criticised China for the “very narrow” definition of COVID-19 deaths and said that the government has not revealed the true impact of the new infections. "We believe that the current numbers being published from China under-represent the true impact of the disease in terms of hospital admissions, in terms of ICU admissions, and particularly in terms of deaths," the WHO's emergencies director Michael Ryan told reporters. Earlier, WHO officials met with a team of Chinese scientists on Tuesday in order to verify the accuracy of China’s COVID-19 data and the latest growth in infections, said an AFP report. The Communist Party of China’s mouthpiece newspaper claimed on Wednesday that the country is pushing for a “final victory” over the pandemic but the numbers are telling a completely different story. The number of Covid cases skyrocketed after relaxation of restrictions in China and in the past few weeks, the hospitals in various parts of the country have been full with patients of all ages. Also read | Omicron offshoot XBB.1.5 may cause new Covid spike in the US, confirms CDC The United Nations has already asked the scientists in China to submit independent data in order to get a clear picture of the situation in China. According to Reuters, the WHO has not received any data from China regarding the COVID-19 cases since the shift in policy by the Chinese government. Chinese President Xi Jinping implemented the strict Zero Covid policy in an attempt to control the infection but in the face of nationwide protests, the government decided to relax some restrictions. WATCH | China: Covid-19 cases on the rise, WHO urges to share real-time data According to local media reports, China had just five deaths related to Covid and around 5258 infections. That is a number which is lesser than the average toll seen in the last six months. The strict restrictions also had a massive impact on the Chinese economy which is currently valued at $17 trillion. However, with the economy opening up, the Chinese yuan is currently going at a four-month high against the United States Dollar as the manufacturing units also resumed operations. (With inputs from agencies)

WHO says data provided by China ‘under-represents’ true impact of Covid outbreak

According to World Health Organization officials, data from China shows no new coronavirus variant has been found there, but it also under-represents how many people have died in the country's rapidly spreading outbreak.

W.H.O. confirms no new variant from China's Covid surge

Three years after the world recorded its first ever case of coronavirus, the central Chinese city of Wuhan and the rest of China once again is in the news thanks to a massive surge in Covid-19 infections.

China: Covid-19 cases on the rise, WHO urges to share real-time data

As more and more countries are imposing restrictions on travellers from China amid the recent surge in cases in the country, Beijing’s state media, called these mandates 'discriminatory'. WHO also urged China's health officials to regularly share specific and real-time information on the situation of the pandemic.

WHO calls up China to step up Covid response, urges to share more Covid data too

Amidst the global alarm of surge the Covid-19 cases in China, the WHO has said that the restrictions imposed by some countries on travelers from China are understandable, given the lack of information from Beijing. At the moment, the WHO Chief has urged China to be more forthcoming on the pandemic situation in the country.

Global alarm over China's Covid surge, travel curbs imposed on Chinese travelers

As more and more countries are imposing restrictions on travellers from China amid the recent surge in cases in the country, Beijing’s state media, called these mandates “discriminatory”. However, the World Health Organization (WHO) chief, on Thursday, called the measures “understandable” given the lack of information from China.&nbsp;

In a statement, the WHO Director-General, Tedros Adhanom Ghebreyesus, urged China to be more forthcoming about the COVID-19 situation in the country.

“We remain concerned about the evolving situation and we continue encouraging China to track the COVID-19 virus and vaccinate the highest risk people. We continue to offer our support for clinical care and protecting its health system,” said Tedros on Twitter.&nbsp;

ALSO READ |&nbsp;<a href="https://www.wionews.com/world/beijing-slams-covid-curbs-on-chinese-travellers-as-discriminatory-547901">Beijing slams Covid curbs on Chinese travellers as 'discriminatory'</a>

This also comes after countries including the United States, India, Italy and Japan, among others and most recently South Korea have mandated Covid tests for travellers from China. “In the absence of comprehensive information from China, it is understandable that countries around the world are acting in ways that they believe may protect their populations. COVID-19,” said the WHO chief. &nbsp;

Notably, no measures have been imposed in the 27-nation bloc, European Union as its health agency says they were not warranted for the moment. However, on Wednesday, at least half of the passengers on a flight from China to Italy tested positive for COVID-19.&nbsp;

Meanwhile, the US has also raised concerns about possible variants of the virus amid the lack of data from China. Similarly, Tedros referring to his recent press conference on the subject also wrote, “in order to make a comprehensive risk assessment of the COVID-19 situation on the ground in China, WHO needs more detailed information.”&nbsp;

ALSO WATCH |&nbsp;<a href="https://www.wionews.com/videos/china-hospitals-under-seige-as-covid-crisis-worsens-547075">China: Hospitals under siege as covid crisis worsens</a>

Tedros had also previously, in a press conference on December 21 expressed concerns about the reports of an uptick in cases emerging from China. As well as called for detailed data on the severity of the disease, hospital admissions and intensive care requirements from China.&nbsp;

The recent uptick in cases has partly been attributed to Beijing’s sudden backtrack from its stringent ‘zero-Covid’ policy, following country-wide protests. Furthermore, several reports suggest that hospitals across China have been overwhelmed by this sudden increase in the number of infections.&nbsp;

ALSO READ |&nbsp;<a href="https://www.wionews.com/world/china-will-see-25k-deaths-a-day-during-covid-peak-in-jan-uk-health-firm-says-547963">China will see 25K deaths a day during Covid peak in Jan, UK health firm says</a>

Whereas Beijing has only reported one death on Thursday and earlier this week said that it would also end its mandatory quarantine on arrival from January 8 prompting people to travel abroad. But inbound passengers are required to produce a negative PCR test within 48 hours before departure.

(With inputs from agencies)&nbsp;

&nbsp;

WATCH WION LIVE HERE

<iframe allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen="" frameborder="0" height="350" loading="”lazy”" src="https://www.wionews.com/live-tv/embed?autoplay=1&amp;mute=1" width="100%"></iframe>

You can now write for wionews.com and be a part of the community. Share your stories and opinions with us <a href="https://www.wionews.com/content-contribution-registration-form">here</a>.

As more and more countries are imposing restrictions on travellers from China amid the recent surge in cases in the country, Beijing’s state media, called these mandates “discriminatory”.

As more and more countries are imposing restrictions on travellers from China amid the recent surge in cases in the country, Beijing’s state media, called these mandates “discriminatory”. However, the World Health Organization (WHO) chief, on Thursday, called the measures “understandable” given the lack of information from China. In a statement, the WHO Director-General, Tedros Adhanom Ghebreyesus, urged China to be more forthcoming about the COVID-19 situation in the country. “We remain concerned about the evolving situation and we continue encouraging China to track the COVID-19 virus and vaccinate the highest risk people. We continue to offer our support for clinical care and protecting its health system,” said Tedros on Twitter. ALSO READ | Beijing slams Covid curbs on Chinese travellers as 'discriminatory' This also comes after countries including the United States, India, Italy and Japan, among others and most recently South Korea have mandated Covid tests for travellers from China. “In the absence of comprehensive information from China, it is understandable that countries around the world are acting in ways that they believe may protect their populations. COVID-19,” said the WHO chief. Notably, no measures have been imposed in the 27-nation bloc, European Union as its health agency says they were not warranted for the moment. However, on Wednesday, at least half of the passengers on a flight from China to Italy tested positive for COVID-19. Meanwhile, the US has also raised concerns about possible variants of the virus amid the lack of data from China. Similarly, Tedros referring to his recent press conference on the subject also wrote, “in order to make a comprehensive risk assessment of the COVID-19 situation on the ground in China, WHO needs more detailed information.” ALSO WATCH | China: Hospitals under siege as covid crisis worsens Tedros had also previously, in a press conference on December 21 expressed concerns about the reports of an uptick in cases emerging from China. As well as called for detailed data on the severity of the disease, hospital admissions and intensive care requirements from China. The recent uptick in cases has partly been attributed to Beijing’s sudden backtrack from its stringent ‘zero-Covid’ policy, following country-wide protests. Furthermore, several reports suggest that hospitals across China have been overwhelmed by this sudden increase in the number of infections. ALSO READ | China will see 25K deaths a day during Covid peak in Jan, UK health firm says Whereas Beijing has only reported one death on Thursday and earlier this week said that it would also end its mandatory quarantine on arrival from January 8 prompting people to travel abroad. But inbound passengers are required to produce a negative PCR test within 48 hours before departure. (With inputs from agencies) WATCH WION LIVE HERE You can now write for wionews.com and be a part of the community. Share your stories and opinions with us here.

WHO ‘concerned’ about increase of COVID-19 cases in China, calls restrictions by countries ‘understandable’

The infectious Coronavirus disease also known as COVID-19 is caused by the SARS-CoV-2 virus. Over time, like all other viruses, SARS-CoV-2 also changes itself. The majority of changes have little to no effect on the characteristics of the virus, but some changes might impact how easily the virus spreads, the severity, or the effectiveness of vaccines.&nbsp;The virus variants so far are categorized by WHO as Variants of Interest (VOIs), Variants under monitoring (VUMs) and Variants of Concern (VOCs).&nbsp;

<h2>What is BF.7 variant?&nbsp;</h2>

SARS-CoV-2 tree sprouts branches and sub-branches meaning as the viruses mutate they change creates lineages and sub-lineages. The Omicron variant comprises four lineages including B.1.1.529, BA.1, BA.2 and BA.3. WHO on 26 November 2021 designated variant B.1.1.529 a variant of concern, named Omicron.

The BF.7 also called by the name BA.5.2.1.7 is a sub-lineage of the Omicron sub-lineage BA.5. As per reports, BF.7 sub-variant has a higher neutralisation resistance meaning antibodies from a vaccinated or infected individual were less likely to destroy BF.7 than the original coronavirus that spread worldwide in 2020. This is not the first time BF.7 is detected as BF.7 accounted for more than 5% of US cases and 7.26% of UK cases in October.&nbsp;

<h2>BF.7 in India, is it a Variant of Concern?&nbsp;</h2>

The BA.1 and BA.2 sub-variants of Omicron were responsible for the January 2022 wave in India. However,&nbsp;India experienced extremely few cases of BF.7. Now the global concern around COVID situation in China has increased. In India, four cases have been found so far of BF.7, two cases each in Gujarat and Odisha. In Odisha, the Omicron BF.7 was detected in a sample testing on 30 September. As per&nbsp;Odisha Health and Family Welfare department cited by multiple media outlets, at the time of testing, BF.7 was neither a VOC (Variant of Concern) nor VOI (Variant of Interest).&nbsp;

<h2>Are vaccines effective on BF.7?</h2>

The virus has mutated many times over since the beginning of 2020. As per reports, the Omicron variants are known to evade the immune response from most vaccines currently in use however getting vaccination is still advisable as it prevents death, as per medical experts.&nbsp;

<h2>Transmission</h2>

The virus can spread from an infected person’s mouth or nose in small liquid particles when they cough, sneeze, speak, sing or breathe. These particles range from larger respiratory droplets to smaller aerosols. It is important to practice respiratory etiquette, for example by coughing into a flexed elbow, and to stay home and self-isolate until you recover if you feel unwell.

Most people infected with the virus will experience mild to moderate respiratory illness and recover without requiring special treatment. However, some will become seriously ill and require medical attention. Older people and those with underlying medical conditions like cardiovascular disease, diabetes, chronic respiratory disease, or cancer are more likely to develop serious illness. Anyone can get sick with COVID-19 and become seriously ill or die at any age.&nbsp;

<h2>Symptoms</h2>

The most common symptoms are fever, cough, tiredness and loss of taste or smell. The less common symptoms are sore throat, headache, aches and pains, diarrhoea, a rash on skin, or discolouration of fingers or toes and red or irritated eyes. Serious symptoms include difficulty breathing or shortness of breath, loss of speech or mobility, confusion and chest pain.

<h2>How to protect yourself?</h2>

The best way to prevent and slow down transmission is to be well informed about the disease and how the virus spreads. Protect yourself and others from infection by staying at least 1 metre apart from others, wearing a properly fitted mask, and washing your hands or using an alcohol-based rub frequently. Get vaccinated when it’s your turn and follow local guidance. Choose open, well-ventilated spaces over closed ones. Open a window if indoors.

<a href="https://www.wionews.com/india-news/coronavirus-live-coverage-covid-latest-news-chaos-in-china-new-guidelines-in-india-pm-modi-to-chair-covid-review-meet-545359">Check Coronavirus Live Updates here</a> 
&nbsp;

The infectious Coronavirus disease also known as COVID-19 is caused by the SARS-CoV-2 virus. Over time, like all other viruses, SARS-CoV-2 also changes itself. The majority of changes have little to no effect on the characteristics of the virus, but some changes might impact how easily the virus spreads, the severity, or the effectiveness of vaccines.

The infectious Coronavirus disease also known as COVID-19 is caused by the SARS-CoV-2 virus. Over time, like all other viruses, SARS-CoV-2 also changes itself. The majority of changes have little to no effect on the characteristics of the virus, but some changes might impact how easily the virus spreads, the severity, or the effectiveness of vaccines. The virus variants so far are categorized by WHO as Variants of Interest (VOIs), Variants under monitoring (VUMs) and Variants of Concern (VOCs). What is BF.7 variant? SARS-CoV-2 tree sprouts branches and sub-branches meaning as the viruses mutate they change creates lineages and sub-lineages. The Omicron variant comprises four lineages including B.1.1.529, BA.1, BA.2 and BA.3. WHO on 26 November 2021 designated variant B.1.1.529 a variant of concern, named Omicron. The BF.7 also called by the name BA.5.2.1.7 is a sub-lineage of the Omicron sub-lineage BA.5. As per reports, BF.7 sub-variant has a higher neutralisation resistance meaning antibodies from a vaccinated or infected individual were less likely to destroy BF.7 than the original coronavirus that spread worldwide in 2020. This is not the first time BF.7 is detected as BF.7 accounted for more than 5% of US cases and 7.26% of UK cases in October. BF.7 in India, is it a Variant of Concern? The BA.1 and BA.2 sub-variants of Omicron were responsible for the January 2022 wave in India. However, India experienced extremely few cases of BF.7. Now the global concern around COVID situation in China has increased. In India, four cases have been found so far of BF.7, two cases each in Gujarat and Odisha. In Odisha, the Omicron BF.7 was detected in a sample testing on 30 September. As per Odisha Health and Family Welfare department cited by multiple media outlets, at the time of testing, BF.7 was neither a VOC (Variant of Concern) nor VOI (Variant of Interest). Are vaccines effective on BF.7? The virus has mutated many times over since the beginning of 2020. As per reports, the Omicron variants are known to evade the immune response from most vaccines currently in use however getting vaccination is still advisable as it prevents death, as per medical experts. Transmission The virus can spread from an infected person’s mouth or nose in small liquid particles when they cough, sneeze, speak, sing or breathe. These particles range from larger respiratory droplets to smaller aerosols. It is important to practice respiratory etiquette, for example by coughing into a flexed elbow, and to stay home and self-isolate until you recover if you feel unwell. Most people infected with the virus will experience mild to moderate respiratory illness and recover without requiring special treatment. However, some will become seriously ill and require medical attention. Older people and those with underlying medical conditions like cardiovascular disease, diabetes, chronic respiratory disease, or cancer are more likely to develop serious illness. Anyone can get sick with COVID-19 and become seriously ill or die at any age. Symptoms The most common symptoms are fever, cough, tiredness and loss of taste or smell. The less common symptoms are sore throat, headache, aches and pains, diarrhoea, a rash on skin, or discolouration of fingers or toes and red or irritated eyes. Serious symptoms include difficulty breathing or shortness of breath, loss of speech or mobility, confusion and chest pain. How to protect yourself? The best way to prevent and slow down transmission is to be well informed about the disease and how the virus spreads. Protect yourself and others from infection by staying at least 1 metre apart from others, wearing a properly fitted mask, and washing your hands or using an alcohol-based rub frequently. Get vaccinated when it’s your turn and follow local guidance. Choose open, well-ventilated spaces over closed ones. Open a window if indoors. Check Coronavirus Live Updates here

EXPLAINED: What is BF.7, the new variant behind China's COVID wave, are available vaccines effective?

The World Health Organisation Director-General Tedros Adhanom Ghebreyesus expressed his concerns regarding the massive increase in COVID-19 cases in China. During a press briefing, the head of the United Nations body said that the WHO is focused on helping governments all around the world in their fight against the infection and the first step will be to make sure that everyone is completely vaccinated.&nbsp;

"The WHO is very concerned over the evolving situation in China, with increasing reports of severe disease," Ghebreyesus told reporters during the briefing according to Reuters.&nbsp;

Also read |&nbsp;<a href="https://www.wionews.com/world/russia-to-continue-improving-combat-readiness-of-nuclear-forces-says-vladimir-putin-545223">Russia to continue improving combat readiness of nuclear forces, says Putin</a>

In the past few weeks, the number of cases has gone up considerably in China and that has also coincided with the government relaxing a number of strict restrictions. The latest set of lockdowns in China resulted in widespread protests and in the face of international pressure, the Communist Party of China under the leadership of President Xi Jinping decided to go back to the Zero Covid policy.&nbsp;

Tedros told reporters that the WHO is still waiting for a detailed report regarding the current situation in China and once the details are clear, the agency will be working on a comprehensive counterplan.&nbsp;

Also read |&nbsp;<a href="https://www.wionews.com/world/watch-exhausted-doctor-collapses-while-attending-patients-amid-chinas-covid-surge-545169">WATCH: Exhausted doctor collapses while attending Covid patients in China</a>

WHO's emergencies director Mike Ryan said that it is a possibility that China is struggling to keep a tab on the total number of infections with irregular testing since the relaxation of the rules.&nbsp;

"In China, what's been reported is relatively low numbers of cases in ICUs, but anecdotally ICUs are filling up. I wouldn't like to say that China is actively not telling us what's going on. I think they're behind the curve," he said in a press conference according to a report by Associated Press.

<iframe allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen="" frameborder="0" height="350" loading="”lazy”" src="https://www.wionews.com/live-tv/embed?autoplay=1&amp;mute=1" width="100%"></iframe>

The World Health Organisation Director-General Tedros Adhanom Ghebreyesus expressed his concerns regarding the massive increase in COVID-19 cases in China. During a press briefing, the head of the United Nations body said that the WHO is focused on helping governments all around the world in their fight against the infection and the first step will be to make sure that everyone is completely vaccinated.

The World Health Organisation Director-General Tedros Adhanom Ghebreyesus expressed his concerns regarding the massive increase in COVID-19 cases in China. During a press briefing, the head of the United Nations body said that the WHO is focused on helping governments all around the world in their fight against the infection and the first step will be to make sure that everyone is completely vaccinated. "The WHO is very concerned over the evolving situation in China, with increasing reports of severe disease," Ghebreyesus told reporters during the briefing according to Reuters. Also read | Russia to continue improving combat readiness of nuclear forces, says Putin In the past few weeks, the number of cases has gone up considerably in China and that has also coincided with the government relaxing a number of strict restrictions. The latest set of lockdowns in China resulted in widespread protests and in the face of international pressure, the Communist Party of China under the leadership of President Xi Jinping decided to go back to the Zero Covid policy. Tedros told reporters that the WHO is still waiting for a detailed report regarding the current situation in China and once the details are clear, the agency will be working on a comprehensive counterplan. Also read | WATCH: Exhausted doctor collapses while attending Covid patients in China WHO's emergencies director Mike Ryan said that it is a possibility that China is struggling to keep a tab on the total number of infections with irregular testing since the relaxation of the rules. "In China, what's been reported is relatively low numbers of cases in ICUs, but anecdotally ICUs are filling up. I wouldn't like to say that China is actively not telling us what's going on. I think they're behind the curve," he said in a press conference according to a report by Associated Press.

WHO chief 'very concerned' with rising number of COVID-19 cases in China

The issue of&nbsp;the deaths of Gambian children blamed on some Indian cough syrups is still in the churn, and the World Health Organization (WHO) has said that it stands by its action of issuing an alert regarding the said medicine.&nbsp;The WHO statement&nbsp;comes after India notified it that samples obtained from the Indian pharmaceutical business Maiden Pharma, whose goods were implicated in the deaths of children in the Gambia, had been deemed to meet the necessary specifications.

Watch&nbsp;|&nbsp;<a href="https://www.wionews.com/videos/gambia-cough-syrup-deaths-after-whos-alert-indian-govts-crackdown-on-maiden-pharma-524790">Gambia cough syrup deaths: After WHO's alert, Indian govt's crackdown on Maiden Pharma</a>

<iframe allowfullscreen="" autoplay="1" frameborder="0" height="350" src="https://www.wionews.com/videos/gambia-cough-syrup-deaths-after-whos-alert-indian-govts-crackdown-on-maiden-pharma-524790/embed" width="560"></iframe>

In a letter to the global health authority dated December 13, India's drugs controller general, VG Somani, said that tests conducted on samples of Maiden Pharma's products "have been found to be complying with specifications". The letter also said that samples were not contaminated with ethylene glycol and diethylene glycol as alleged.

Talking to BBC via email, the health agency said, "WHO's mandate is to issue global alerts about potential risks. WHO stands by the action taken," adding that "contaminated syrups are dangerous and should not be in any medicine, ever".

Also read |&nbsp;<a href="https://www.wionews.com/india-news/who-drew-premature-link-between-gambia-deaths-and-india-made-cough-syrups-543653">WHO drew 'premature link' between Gambia deaths and India-made cough syrups</a>

WHO in October said that its investigators had found "unacceptable" levels of the two chemicals in Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold Syrup; cough syrups made by Maiden Pharmaceuticals, an Indian company.&nbsp;

These chemicals have been known to be toxic and can cause kidney damage.

Also read |&nbsp;<a href="https://www.wionews.com/india-news/india-committee-to-who-information-on-killer-cough-syrups-inadequate-525793">India committee tells WHO: Information on 'killer' cough syrups 'inadequate'</a>

In the letter addressed to WHO's director of regulation and prequalification Roderigo Gaspar, Somani claimed that the health agency's October statement connecting the deaths to the cough syrup made in India had done "irreparable damage" to the nation's pharmaceutical supply chain.

(With inputs from agencies)

WATCH WION LIVE HERE

<iframe allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen="" frameborder="0" height="350" loading="”lazy”" src="https://www.wionews.com/live-tv/embed?autoplay=1&amp;mute=1" width="100%"></iframe>

You can now write for wionews.com and be a part of the community. Share your stories and opinions with us <a href="https://www.wionews.com/content-contribution-registration-form">here</a>.

The issue of the deaths of Gambian children blamed on some Indian cough syrups is still in the churn, and the World Health Organization (WHO) has said that it stands by its action of issuing an alert regarding the said medicine.

The issue of the deaths of Gambian children blamed on some Indian cough syrups is still in the churn, and the World Health Organization (WHO) has said that it stands by its action of issuing an alert regarding the said medicine. The WHO statement comes after India notified it that samples obtained from the Indian pharmaceutical business Maiden Pharma, whose goods were implicated in the deaths of children in the Gambia, had been deemed to meet the necessary specifications. Watch | Gambia cough syrup deaths: After WHO's alert, Indian govt's crackdown on Maiden Pharma In a letter to the global health authority dated December 13, India's drugs controller general, VG Somani, said that tests conducted on samples of Maiden Pharma's products "have been found to be complying with specifications". The letter also said that samples were not contaminated with ethylene glycol and diethylene glycol as alleged. Talking to BBC via email, the health agency said, "WHO's mandate is to issue global alerts about potential risks. WHO stands by the action taken," adding that "contaminated syrups are dangerous and should not be in any medicine, ever". Also read | WHO drew 'premature link' between Gambia deaths and India-made cough syrups WHO in October said that its investigators had found "unacceptable" levels of the two chemicals in Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold Syrup; cough syrups made by Maiden Pharmaceuticals, an Indian company. These chemicals have been known to be toxic and can cause kidney damage. Also read | India committee tells WHO: Information on 'killer' cough syrups 'inadequate' In the letter addressed to WHO's director of regulation and prequalification Roderigo Gaspar, Somani claimed that the health agency's October statement connecting the deaths to the cough syrup made in India had done "irreparable damage" to the nation's pharmaceutical supply chain. (With inputs from agencies) WATCH WION LIVE HERE You can now write for wionews.com and be a part of the community. Share your stories and opinions with us here.

Gambia deaths: WHO stands by its action of issuing alert regarding the Indian cough medicine

Who, News on Who, stories on Who, articles on Who, Who stories at Wion, Who news, Who latest news